Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Previous issues

Page Path
HOME > Browse > Previous issues
13 Previous issues
Filter
Filter
Article category
Keywords
Authors
Funded articles
Volume 37(6); December 2013
Prev issue Next issue
Reviews
Targeting the Peroxisome Proliferator-Activated Receptor-γ to Counter the Inflammatory Milieu in Obesity
Cesar Corzo, Patrick R. Griffin
Diabetes Metab J. 2013;37(6):395-403.   Published online December 12, 2013
DOI: https://doi.org/10.4093/dmj.2013.37.6.395
  • 3,729 View
  • 29 Download
  • 34 Crossref
AbstractAbstract PDFPubReader   

Adipose tissue, which was once viewed as a simple organ for storage of triglycerides, is now considered an important endocrine organ. Abnormal adipose tissue mass is associated with defects in endocrine and metabolic functions which are the underlying causes of the metabolic syndrome. Many adipokines, hormones secreted by adipose tissue, regulate cells from the immune system. Interestingly, most of these adipokines are proinflammatory mediators, which increase dramatically in the obese state and are believed to be involved in the pathogenesis of insulin resistance. Drugs that target peroxisome proliferator-activated receptor-γ have been shown to possess anti-inflammatory effects in animal models of diabetes. These findings, and the link between inflammation and the metabolic syndrome, will be reviewed here.

Citations

Citations to this article as recorded by  
  • Lysine 222 in PPAR γ1 functions as the key site of MuRF2-mediated ubiquitination modification
    Yucheng Fan, Fangjing Xu, Rui Wang, Jun He
    Scientific Reports.2023;[Epub]     CrossRef
  • Heart failure and diabetes: Clinical significance and epidemiology of this two‐way association
    Terri Jerkins, Janet B. McGill, David S. H. Bell
    Diabetes, Obesity and Metabolism.2023; 25(S3): 3.     CrossRef
  • The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeutics
    Gargi Dixit, Arati Prabhu
    Experimental and Molecular Pathology.2022; 124: 104723.     CrossRef
  • The Effect of PPARγ rs1801282 Variant on Mortality Risk Among Asians With Chronic Kidney Disease: A Cohort Study and Meta-Analysis
    Wei-Teing Chen, Chih-Chien Chiu, Dung-Jang Tsai, Pi-Shao Ko, Meng-Chang Lee, Hsiao-Ting Lin, Ying-Kai Chen, Wen Su, Yuh-Feng Lin, Sui-Lung Su
    Frontiers in Genetics.2022;[Epub]     CrossRef
  • Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC
    Hyunmi Kim, Da Som Lee, Tae Hyeon An, Hyun-Ju Park, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh
    International Journal of Molecular Sciences.2021; 22(9): 4495.     CrossRef
  • Associations between obesity-related gene expression in maternal and cord blood and newborn adiposity: findings from the Araraquara Cohort study
    P. Nakandakare, C. F. Nicoletti, N. Y. Noronha, C. B. Nonino, P. P. Argentato, N. N. Dejani, L. A. Luzia, M. M. Rogero, P. H. C. Rondó
    International Journal of Obesity.2021; 45(9): 1958.     CrossRef
  • PPARG Pro12Ala Polymorphism with CKD in Asians: A Meta-Analysis Combined with a Case-Control Study—A Key for Reaching Null Association
    Hsiang-Cheng Chen, Wei-Teing Chen, Tzu-Ling Sung, Dung-Jang Tsai, Chin Lin, Hao Su, Yuh-Feng Lin, Hung-Yi Chiu, Sui-Lung Su
    Genes.2020; 11(6): 705.     CrossRef
  • Induction of peroxisome proliferator activated receptor γ (PPARγ) mediated gene expression and inhibition of induced nitric oxide production by Maerua subcordata (Gilg) DeWolf
    Mebrahtom Gebrelibanos Hiben, Laura de Haan, Bert Spenkelink, Sebastiaan Wesseling, Jacques Vervoort, Ivonne M. C. M. Rietjens
    BMC Complementary Medicine and Therapies.2020;[Epub]     CrossRef
  • UPR modulation of host immunity by Pseudomonas aeruginosa in cystic fibrosis
    Brahmchetna Bedi, Kuo-Chuan. Lin, Nicholas M. Maurice, Zhihong Yuan, Kaiser Bijli, Michael Koval, C. Michael Hart, Joanna B. Goldberg, Arlene Stecenko, Ruxana T. Sadikot
    Clinical Science.2020; 134(14): 1911.     CrossRef
  • Sepsis Immunometabolism: From Defining Sepsis to Understanding How Energy Production Affects Immune Response
    Ioannis Koutroulis, Rachael Batabyal, Brittany McNamara, Matthew Ledda, Claire Hoptay, Robert J. Freishtat
    Critical Care Explorations.2019; 1(11): e0061.     CrossRef
  • Combining SGLT2 Inhibition With a Thiazolidinedione Additively Attenuate the Very Early Phase of Diabetic Nephropathy Progression in Type 2 Diabetes Mellitus
    Eugene Han, Eugene Shin, Gyuri Kim, Ji-Yeon Lee, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha
    Frontiers in Endocrinology.2018;[Epub]     CrossRef
  • Role of oral hypoglycemic drugs on inflammatory condition associated with type 2 diabetes mellitus
    Shamim Shaikh Mohiuddin
    Journal of Diabetes, Metabolic Disorders & Control.2018; 5(2): 78.     CrossRef
  • Effects of lobeglitazone on insulin resistance and hepatic steatosis in high-fat diet-fed mice
    Bong-Hoi Choi, Zhen Jin, Chin-ok Yi, Juhong Oh, Eun Ae Jeong, Jong Youl Lee, Kyung-ah Park, Kyung Eun Kim, Jung Eun Lee, Hyun-Jin Kim, Jong Ryeal Hahm, Gu Seob Roh, Jonathan M Peterson
    PLOS ONE.2018; 13(7): e0200336.     CrossRef
  • Cucurbita ficifolia (Cucurbitaceae) modulates inflammatory cytokines and IFN-γ in obese mice
    Á. Fortis-Barrera, R. García-Macedo, J.C. Almanza-Perez, G. Blancas-Flores, A. Zamilpa-Alvarez, J.L. Flores-Sáenz, M. Cruz, R. Román-Ramos, F.J. Alarcón-Aguilar
    Canadian Journal of Physiology and Pharmacology.2017; 95(2): 170.     CrossRef
  • Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness
    Yong-ho Lee, Jae Hyeon Kim, So Ra Kim, Heung Yong Jin, Eun-Jung Rhee, Young Min Cho, Byung-Wan Lee
    Journal of Korean Medical Science.2017; 32(1): 60.     CrossRef
  • Peroxisome proliferator‐activated receptor‐γ agonists attenuate biofilm formation by Pseudomonas aeruginosa
    Brahmchetna Bedi, Nicholas M. Maurice, Vincent T. Ciavatta, K. Sabrina Lynn, Zhihong Yuan, Samuel A. Molina, Myungsoo Joo, William R. Tyor, Joanna B. Goldberg, Michael Koval, C. Michael Hart, Ruxana T. Sadikot
    The FASEB Journal.2017; 31(8): 3608.     CrossRef
  • Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
    Marit de Jong, H. Bart van der Worp, Yolanda van der Graaf, Frank L. J. Visseren, Jan Westerink
    Cardiovascular Diabetology.2017;[Epub]     CrossRef
  • Gestational diabetes mellitus was related to ambient air pollutant nitric oxide during early gestation
    Shih-Chun Pan, Ching-Chun Huang, Shio-Jean Lin, Bing-Yu Chen, Chang-Chuan Chan, Yue-Liang Leon Guo
    Environmental Research.2017; 158: 318.     CrossRef
  • The Multifaceted Haptoglobin in the Context of Adipose Tissue and Metabolism
    Margherita Maffei, Ilaria Barone, Gaia Scabia, Ferruccio Santini
    Endocrine Reviews.2016; 37(4): 403.     CrossRef
  • Enhanced Clearance of Pseudomonas aeruginosa by Peroxisome Proliferator-Activated Receptor Gamma
    Brahmchetna Bedi, Zhihong Yuan, Myungsoo Joo, Susu M. Zughaier, Joanna B. Goldberg, Jack L. Arbiser, C. Michael Hart, Ruxana T. Sadikot, B. A. McCormick
    Infection and Immunity.2016; 84(7): 1975.     CrossRef
  • F-box only protein 9 is an E3 ubiquitin ligase of PPARγ
    Kyeong Won Lee, Soo Heon Kwak, Young Do Koo, Yun-Kyung Cho, Hak Mo Lee, Hye Seung Jung, Young Min Cho, Young Joo Park, Sung Soo Chung, Kyong Soo Park
    Experimental & Molecular Medicine.2016; 48(5): e234.     CrossRef
  • The Resin fromProtium heptaphyllumPrevents High-Fat Diet-Induced Obesity in Mice: Scientific Evidence and Potential Mechanisms
    Karine Maria Martins Bezerra Carvalho, José Delano Barreto Marinho Filho, Tiago Sousa de Melo, Ana Jérsia Araújo, Josiane da Silva Quetz, Maria do Perpétuo Socorro Saldanha da Cunha, Karina Moura de Melo, Armenio Andre de Carvalho Almeida da Silva, Adrian
    Evidence-Based Complementary and Alternative Medicine.2015; 2015: 1.     CrossRef
  • Lobeglitazone and pioglitazone as add‐ons to metformin for patients with type 2 diabetes: a 24‐week, multicentre, randomized, double‐blind, parallel‐group, active‐controlled, phase III clinical trial with a 28‐week extension
    S.‐M. Jin, C.‐Y. Park, Y. M. Cho, B. J. Ku, C. W. Ahn, B.‐S. Cha, K. W. Min, Y. A. Sung, S. H. Baik, K. W. Lee, K.‐H. Yoon, M.‐K. Lee, S. W. Park
    Diabetes, Obesity and Metabolism.2015; 17(6): 599.     CrossRef
  • Deconvolution of Complex 1D NMR Spectra Using Objective Model Selection
    Travis S. Hughes, Henry D. Wilson, Ian Mitchelle S. de Vera, Douglas J. Kojetin, Paul C. Driscoll
    PLOS ONE.2015; 10(8): e0134474.     CrossRef
  • PPARγ partial agonist GQ-16 strongly represses a subset of genes in 3T3-L1 adipocytes
    Flora Aparecida Milton, Aleksandra Cvoro, Angelica A. Amato, Douglas H. Sieglaff, Carly S. Filgueira, Anithachristy Sigamani Arumanayagam, Maria do Carmo Alves de Lima, Ivan Rocha Pitta, Francisco de Assis Rocha Neves, Paul Webb
    Biochemical and Biophysical Research Communications.2015; 464(3): 718.     CrossRef
  • Voluntary exercise prevents colonic inflammation in high-fat diet-induced obese mice by up-regulating PPAR-γ activity
    Wei-Xin Liu, Ting Wang, Feng Zhou, Ying Wang, Jun-Wei Xing, Shen Zhang, Shou-Zhi Gu, Li-Xuan Sang, Cong Dai, Hai-Lan Wang
    Biochemical and Biophysical Research Communications.2015; 459(3): 475.     CrossRef
  • Effect of a new PPAR-gamma agonist, lobeglitazone, on neointimal formation after balloon injury in rats and the development of atherosclerosis
    Soo Lim, Kuy-Sook Lee, Jie Eun Lee, Ho Seon Park, Kyoung Min Kim, Jae Hoon Moon, Sung Hee Choi, Kyong Soo Park, Young Bum Kim, Hak Chul Jang
    Atherosclerosis.2015; 243(1): 107.     CrossRef
  • Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control
    A.J. Scheen, N. Esser, N. Paquot
    Diabetes & Metabolism.2015; 41(3): 183.     CrossRef
  • Genomic binding and regulation of gene expression by the thyroid carcinoma-associated PAX8-PPARG fusion protein
    Yanxiao Zhang, Jingcheng Yu, Chee Lee, Bin Xu, Maureen A. Sartor, Ronald J. Koenig
    Oncotarget.2015; 6(38): 40418.     CrossRef
  • Peroxisome Proliferator-Activated Receptor γ (PPARγ) and Ligand Choreography: Newcomers Take the Stage
    Santiago Garcia-Vallvé, Laura Guasch, Sarah Tomas-Hernández, Josep Maria del Bas, Vincent Ollendorff, Lluís Arola, Gerard Pujadas, Miquel Mulero
    Journal of Medicinal Chemistry.2015; 58(14): 5381.     CrossRef
  • Pathway Analysis of Metabolic Syndrome Using a Genome-Wide Association Study of Korea Associated Resource (KARE) Cohorts
    Unjin Shim, Han-Na Kim, Yeon-Ah Sung, Hyung-Lae Kim
    Genomics & Informatics.2014; 12(4): 195.     CrossRef
  • Pax-8–PPAR-γ fusion protein in thyroid carcinoma
    Priyadarshini Raman, Ronald J. Koenig
    Nature Reviews Endocrinology.2014; 10(10): 616.     CrossRef
  • Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients: a systemic review and meta-analysis
    Shinan Yin, Hua Bai, Danqing Jing
    Diagnostic Pathology.2014;[Epub]     CrossRef
  • Common biological mechanisms between bipolar disorder and type 2 diabetes: Focus on inflammation
    Ajaykumar N. Sharma, Isabelle E. Bauer, Marsal Sanches, Juan F. Galvez, Giovana B. Zunta-Soares, Joao Quevedo, Flavio Kapczinski, Jair C. Soares
    Progress in Neuro-Psychopharmacology and Biological Psychiatry.2014; 54: 289.     CrossRef
Resistin in Rodents and Humans
Hyeong Kyu Park, Rexford S. Ahima
Diabetes Metab J. 2013;37(6):404-414.   Published online December 12, 2013
DOI: https://doi.org/10.4093/dmj.2013.37.6.404
  • 5,588 View
  • 52 Download
  • 121 Crossref
AbstractAbstract PDFPubReader   

Obesity is characterized by excess accumulation of lipids in adipose tissue and other organs, and chronic inflammation associated with insulin resistance and an increased risk of type 2 diabetes. Obesity, type 2 diabetes, and cardiovascular diseases are major health concerns. Resistin was first discovered as an adipose-secreted hormone (adipokine) linked to obesity and insulin resistance in rodents. Adipocyte-derived resistin is increased in obese rodents and strongly related to insulin resistance. However, in contrast to rodents, resistin is expressed and secreted from macrophages in humans and is increased in inflammatory conditions. Some studies have also suggested an association between increased resistin levels and insulin resistance, diabetes and cardiovascular disease. Genetic studies have provided additional evidence for a role of resistin in insulin resistance and inflammation. Resistin appears to mediate the pathogenesis of atherosclerosis by promoting endothelial dysfunction, vascular smooth muscle cell proliferation, arterial inflammation, and formation of foam cells. Indeed, resistin is predictive of atherosclerosis and poor clinical outcomes in patients with coronary artery disease and ischemic stroke. There is also growing evidence that elevated resistin is associated with the development of heart failure. This review will focus on the biology of resistin in rodents and humans, and evidence linking resistin with type 2 diabetes, atherosclerosis, and cardiovascular disease.

Citations

Citations to this article as recorded by  
  • Resistin – A Plausible Therapeutic Target in the Pathogenesis of Psoriasis
    Manupati Srikanth, Mahaboobkhan Rasool
    Immunological Investigations.2024; 53(2): 115.     CrossRef
  • MHO or MUO? White adipose tissue remodeling
    Jing Yi Zhao, Li Juan Zhou, Kai Le Ma, Rui Hao, Min Li
    Obesity Reviews.2024;[Epub]     CrossRef
  • Resistin in endocrine pancreas of sheep: Presence and expression related to different diets
    Margherita Maranesi, Elisa Palmioli, Cecilia Dall'Aglio, Daniele Marini, Polina Anipchenko, Elena De Felice, Paola Scocco, Francesca Mercati
    General and Comparative Endocrinology.2024; 348: 114452.     CrossRef
  • Adipocytokines levels as potential biomarkers for discriminating patients with a diagnosis of depressive disorder from healthy controls
    Elżbieta Małujło-Balcerska, Tadeusz Pietras
    Journal of Psychiatric Research.2024; 171: 163.     CrossRef
  • Adipokines in atopic dermatitis: the link between obesity and atopic dermatitis
    Shiyun Zhang, Bingjie Zhang, Yuehua Liu, Li Li
    Lipids in Health and Disease.2024;[Epub]     CrossRef
  • The Role of Adipokines in the Control of Pituitary Functions
    Barbara Kaminska, Beata Kurowicka, Marta Kiezun, Kamil Dobrzyn, Katarzyna Kisielewska, Marlena Gudelska, Grzegorz Kopij, Karolina Szymanska, Barbara Zarzecka, Oguzhan Koker, Ewa Zaobidna, Nina Smolinska, Tadeusz Kaminski
    Animals.2024; 14(2): 353.     CrossRef
  • Adipokine imbalance and its role in the pathogenesis of novel coronavirus infection
    I. D. Bespalova, U. M. Mitrichenko, V. V. Kalyuzhin, E. S. Koroleva, Yu. I. Koshchavtseva, D. S. Romanov, D. E. Pershina
    Bulletin of Siberian Medicine.2024; 22(4): 164.     CrossRef
  • Association of adipokine levels with obesity in periodontal health and disease: A systematic review with meta‐analysis and meta‐regression
    Eswar Kandaswamy, Chun‐Teh Lee, Soumya Bardvalli Gururaj, Sachin Shivanaikar, Vinayak M. Joshi
    Journal of Periodontal Research.2024;[Epub]     CrossRef
  • Association of maternal body composition and diet on breast milk hormones and neonatal growth during the first month of lactation
    David Ramiro-Cortijo, Pratibha Singh, Gloria Herranz Carrillo, Andrea Gila-Díaz, María A. Martín-Cabrejas, Camilia R. Martin, Silvia M. Arribas
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Upregulation of peripheral blood mononuclear cells resistin gene expression in severe obstructive sleep apnea and obstructive sleep apnea with coexisting type 2 diabetes mellitus
    Branislava Rajkov, Marija Zdravković, Ana Ninić, Milica Brajković, Slobodan Klašnja, Vera Gardijan, Lidija Memon, Jelena Munjas, Marija Mihajlović, Vesna Spasojević- Kalimanovska, Vojislav Radosavljević, Miron Sopić
    Sleep and Breathing.2023; 27(5): 2031.     CrossRef
  • Fat-to-heart crosstalk in health and disease
    Fleur Lodewijks, Timothy A. McKinsey, Emma L. Robinson
    Frontiers in Genetics.2023;[Epub]     CrossRef
  • Adipokines as Diagnostic and Prognostic Markers for the Severity of COVID-19
    Thomas Grewal, Christa Buechler
    Biomedicines.2023; 11(5): 1302.     CrossRef
  • Role of adipokines in sarcopenia
    Wenhao Lu, Wenjie Feng, Jieyu Lai, Dongliang Yuan, Wenfeng Xiao, Yusheng Li
    Chinese Medical Journal.2023; 136(15): 1794.     CrossRef
  • Resistin, TNF-α, and microRNA 124-3p expressions in peripheral blood mononuclear cells are associated with diabetic nephropathy
    Amin Monjezi, Azam Khedri, Mehrnoosh Zakerkish, Ghorban Mohammadzadeh
    International Journal of Diabetes in Developing Countries.2022; 42(1): 62.     CrossRef
  • Resistin in Urine and Breast Milk: Relation to Type of Feeding and Anthropometry at 1-Month
    Irena Santosa, Hiromichi Shoji, Kentaro Awata, Yoshiteru Arai, Hiroki Suganuma, Toshiaki Shimizu
    Pediatric Reports.2022; 14(1): 86.     CrossRef
  • High Serum Levels of Resistin is Associated With Acute Cerebral Infarction
    Kee Ook Lee, Kyung-Yul Lee, Cheol-Young Lee, Ji Hoon Kim, Jaeku Kang, Hoi Young Lee, Sang-Jun Na, Seung-Hun Oh, Ji Hoe Heo
    The Neurologist.2022; 27(2): 41.     CrossRef
  • Resistin production does not affect outcomes in a mouse model of acute surgical sepsis
    Anthony S. Bonavia, Zissis C. Chroneos, Victor Ruiz-Velasco, Charles H. Lang, Partha Mukhopadhyay
    PLOS ONE.2022; 17(3): e0265241.     CrossRef
  • Single-nucleotide polymorphisms as important risk factors of diabetes among Middle East population
    Iman Akhlaghipour, Amir Reza Bina, Mohammad Reza Mogharrabi, Ali Fanoodi, Amir Reza Ebrahimian, Soroush Khojasteh Kaffash, Atefeh Babazadeh Baghan, Mohammad Erfan Khorashadizadeh, Negin Taghehchian, Meysam Moghbeli
    Human Genomics.2022;[Epub]     CrossRef
  • Synergistic Effects of Weighted Genetic Risk Scores and Resistin and sST2 Levels on the Prognostication of Long-Term Outcomes in Patients with Coronary Artery Disease
    Hsin-Hua Chou, Lung-An Hsu, Jyh-Ming Jimmy Juang, Fu-Tien Chiang, Ming-Sheng Teng, Semon Wu, Yu-Lin Ko
    International Journal of Molecular Sciences.2022; 23(8): 4292.     CrossRef
  • Hypoxia Increases the Potential for Neutrophil-mediated Endothelial Damage in Chronic Obstructive Pulmonary Disease
    Katharine M. Lodge, Arlette Vassallo, Bin Liu, Merete Long, Zhen Tong, Paul R. Newby, Danya Agha-Jaffar, Koralia Paschalaki, Clara E. Green, Kylie B. R. Belchamber, Victoria C. Ridger, Robert A. Stockley, Elizabeth Sapey, Charlotte Summers, Andrew S. Cowb
    American Journal of Respiratory and Critical Care Medicine.2022; 205(8): 903.     CrossRef
  • The Role of the Adipokine Resistin in the Pathogenesis and Progression of Epithelial Ovarian Cancer
    Klaudia Parafiniuk, Wiktoria Skiba, Anna Pawłowska, Dorota Suszczyk, Aleksandra Maciejczyk, Iwona Wertel
    Biomedicines.2022; 10(4): 920.     CrossRef
  • Resistin Modulates Low-Density Lipoprotein Cholesterol Uptake in Human Placental Explants via PCSK9
    Sonia Nava-Salazar, Arturo Flores-Pliego, Giovanni Pérez-Martínez, Sandra Parra-Hernández, America Vanoye-Carlo, Francisco Ibarguengoitia-Ochoa, Otilia Perichart-Perera, Enrique Reyes-Muñoz, Juan Mario Solis-Paredes, Salvador Espino y Sosa, Guadalupe Estr
    Reproductive Sciences.2022; 29(11): 3242.     CrossRef
  • Differential Association of Selected Adipocytokines, Adiponectin, Leptin, Resistin, Visfatin and Chemerin, with the Pathogenesis and Progression of Type 2 Diabetes Mellitus (T2DM) in the Asir Region of Saudi Arabia: A Case Control Study
    Mohammad Muzaffar Mir, Rashid Mir, Mushabab Ayed Abdullah Alghamdi, Javed Iqbal Wani, Zia Ul Sabah, Mohammed Jeelani, Vijaya Marakala, Shahzada Khalid Sohail, Mohamed O’haj, Muffarah Hamid Alharthi, Mohannad Mohammad S. Alamri
    Journal of Personalized Medicine.2022; 12(5): 735.     CrossRef
  • Immune system and sarcopenia: Presented relationship and future perspective
    Xuzhi Zhang, Hengzhen Li, Miao He, Jingyu Wang, Yuxiang Wu, Yusheng Li
    Experimental Gerontology.2022; 164: 111823.     CrossRef
  • Adipose Tissue Secretion Pattern Influences β-Cell Wellness in the Transition from Obesity to Type 2 Diabetes
    Giuseppina Biondi, Nicola Marrano, Anna Borrelli, Martina Rella, Giuseppe Palma, Isabella Calderoni, Edoardo Siciliano, Pasquale Lops, Francesco Giorgino, Annalisa Natalicchio
    International Journal of Molecular Sciences.2022; 23(10): 5522.     CrossRef
  • Supplemental hydroxychloroquine therapy regulates adipokines in patients with systemic lupus erythematosus with stable disease
    Risa Wakiya, Kiyo Ueeda, Hiromi Shimada, Shusaku Nakashima, Tomohiro Kameda, Nobuyuki Miyatake, Mikiya Kato, Taichi Miyagi, Koichi Sugihara, Mao Mizusaki, Rina Mino, Norimitsu Kadowaki, Hiroaki Dobashi
    Clinical Rheumatology.2022; 41(11): 3345.     CrossRef
  • Can soy isoflavones in combination with soy protein change serum concentration of adiponectin and resistin? A systematic review and meta‐analysis on randomized clinical trials
    Mitra Hariri, Bahareh Amirkalali, Ensiyeh Mollanoroozy, Ali Gholami
    Food Science & Nutrition.2022; 10(12): 4126.     CrossRef
  • Adipokines: Deciphering the cardiovascular signature of adipose tissue
    Joseph C. Galley, Shubhnita Singh, Wanessa M.C. Awata, Juliano V. Alves, Thiago Bruder-Nascimento
    Biochemical Pharmacology.2022; 206: 115324.     CrossRef
  • Evaluation of the Anti-Obesity Effect of Zeaxanthin and Exercise in HFD-Induced Obese Rats
    Mona Al-thepyani, Salha Algarni, Hana Gashlan, Mohamed Elzubier, Lina Baz
    Nutrients.2022; 14(23): 4944.     CrossRef
  • Single High-Dose Vitamin D Supplementation as an Approach for Reducing Ultramarathon-Induced Inflammation: A Double-Blind Randomized Controlled Trial
    Jan Mieszkowski, Andżelika Borkowska, Błażej Stankiewicz, Andrzej Kochanowicz, Bartłomiej Niespodziński, Marcin Surmiak, Tomasz Waldziński, Rafał Rola, Miroslav Petr, Jędrzej Antosiewicz
    Nutrients.2021; 13(4): 1280.     CrossRef
  • Resistin mitigates stemness and metabolic profile of human adipose-derived mesenchymal stem cells via insulin resistance
    Komal Rawal, Kishan M. Purohit, Tushar P. Patel, Neeta Karont, Sarita Gupta
    Cytokine.2021; 138: 155374.     CrossRef
  • Resistin is co-secreted with adiponectin in white mouse adipocytes
    Saliha Musovic, Man Mohan Shrestha, Ali M. Komai, Charlotta S. Olofsson
    Biochemical and Biophysical Research Communications.2021; 534: 707.     CrossRef
  • Resistin: Potential biomarker and therapeutic target in atherosclerosis
    Li Zhou, Jun-Yi Li, Ping-Ping He, Xiao-Hua Yu, Chao-Ke Tang
    Clinica Chimica Acta.2021; 512: 84.     CrossRef
  • The circulating levels of CTRP1 and CTRP5 are associated with obesity indices and carotid intima-media thickness (cIMT) value in patients with type 2 diabetes: a preliminary study
    Ziba Majidi, Solaleh Emamgholipour, Abolfazl Omidifar, Soheil Rahmani Fard, Hossein Poustchi, Mehrnoosh Shanaki
    Diabetology & Metabolic Syndrome.2021;[Epub]     CrossRef
  • Corylin reduces obesity and insulin resistance and promotes adipose tissue browning through SIRT-1 and β3-AR activation
    Chin-Chuan Chen, Chen-Hsin Kuo, Yann-Lii Leu, Shu-Huei Wang
    Pharmacological Research.2021; 164: 105291.     CrossRef
  • A Focused Review of the Metabolic Side-Effects of Clozapine
    Jessica W. Y. Yuen, David D. Kim, Ric M. Procyshyn, William J. Panenka, William G. Honer, Alasdair M. Barr
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer’s Disease, the 5XFAD Mouse
    Antonio J. López-Gambero, Cristina Rosell-Valle, Dina Medina-Vera, Juan Antonio Navarro, Antonio Vargas, Patricia Rivera, Carlos Sanjuan, Fernando Rodríguez de Fonseca, Juan Suárez
    International Journal of Molecular Sciences.2021; 22(10): 5365.     CrossRef
  • Resistin in pregnancy: Analysis of determinants in pairs of umbilical cord blood and maternal serum
    Anne Floeck, Nina Ferrari, Christine Joisten, Maria T. Puth, Brigitte Strizek, Ramona Dolscheid-Pommerich, Ulrich Gembruch, Waltraut M. Merz
    Cytokine: X.2021; 3(2): 100052.     CrossRef
  • Is resistin the master link between inflammation and inflammation-related chronic diseases?
    Mohammed Taouis, Yacir Benomar
    Molecular and Cellular Endocrinology.2021; 533: 111341.     CrossRef
  • The dynamics of human bone marrow adipose tissue in response to feeding and fasting
    Pouneh K. Fazeli, Miriam A. Bredella, Gisela Pachon-Peña, Wenxiu Zhao, Xun Zhang, Alexander T. Faje, Megi Resulaj, Sai P. Polineni, Tara M. Holmes, Hang Lee, Elizabeth K. O’Donnell, Ormond A. MacDougald, Mark C. Horowitz, Clifford J. Rosen, Anne Klibanski
    JCI Insight.2021;[Epub]     CrossRef
  • Resistin: A journey from metabolism to cancer
    Ankita Deb, Bhavana Deshmukh, Pranay Ramteke, Firoz Khan Bhati, Manoj Kumar Bhat
    Translational Oncology.2021; 14(10): 101178.     CrossRef
  • Obesity is the basis of metabolic syndrome
    A. F. Verbovoy, N. I. Verbovaya, Yu. A. Dolgikh
    Obesity and metabolism.2021; 18(2): 142.     CrossRef
  • Human Milk Metabolic Hormones: Analytical Methods and Current Understanding
    Majed A. Suwaydi, Zoya Gridneva, Sharon L. Perrella, Mary E. Wlodek, Ching Tat Lai, Donna T. Geddes
    International Journal of Molecular Sciences.2021; 22(16): 8708.     CrossRef
  • Adipokines as Immune Cell Modulators in Multiple Sclerosis
    Merel Rijnsburger, Niek Djuric, Inge A. Mulder, Helga E. de Vries
    International Journal of Molecular Sciences.2021; 22(19): 10845.     CrossRef
  • The Role of Adipokines in Cardiovascular Pathology
    Valery Podzolkov , Anna Pokrovskaya, Ulyana Bazhanova , Tatyana Vargina , Svetlana Anatolievna Knyazeva , Daria Vanina
    Open Access Macedonian Journal of Medical Sciences.2021; 9(F): 794.     CrossRef
  • Measurement of Plasma Resistin Concentrations in Horses with Metabolic and Inflammatory Disorders
    Beatriz Fuentes-Romero, Alberto Muñoz-Prieto, José J. Cerón, María Martín-Cuervo, Manuel Iglesias-García, Escolástico Aguilera-Tejero, Elisa Díez-Castro
    Animals.2021; 12(1): 77.     CrossRef
  • EFFECT OF DIET AND EXERCISE-INDUCE WEIGHT LOSS ON LEVEL OF RESISTIN IN PATIENT WITH OBESITY
    О. I. Tokarenko, I. O. Andreieva, O. O. Tokarenko, M. M. Surmilo
    Modern medical technology.2021; (4): 11.     CrossRef
  • Alteration of gut microbiota affects expression of adiponectin and resistin through modifying DNA methylation in high-fat diet-induced obese mice
    Hongyang Yao, Chaonan Fan, Yuanyuan Lu, Xiuqin Fan, Lulu Xia, Ping Li, Rui Wang, Tiantian Tang, Yuanyuan Wang, Kemin Qi
    Genes & Nutrition.2020;[Epub]     CrossRef
  • Resistin hormone in diabetic kidney disease and its relation to iron status and hepcidin
    Zhian Sherzad Hayder, Zrar Saleem Kareem
    International Urology and Nephrology.2020; 52(4): 749.     CrossRef
  • Proteoglycans in Obesity-Associated Metabolic Dysfunction and Meta-Inflammation
    Ariane R. Pessentheiner, G. Michelle Ducasa, Philip L. S. M. Gordts
    Frontiers in Immunology.2020;[Epub]     CrossRef
  • Resistin Is Increased in Periodontal Cells and Tissues: In Vitro and In Vivo Studies
    Andressa V. B. Nogueira, Marjan Nokhbehsaim, Sema Tekin, Rafael S. de Molon, Luis C. Spolidorio, Svenja Memmert, Anna Damanaki, Andreas Jäger, Sigrun Eick, James Deschner, Joni A. Cirelli
    Mediators of Inflammation.2020; 2020: 1.     CrossRef
  • Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease
    Alan Chait, Laura J. den Hartigh
    Frontiers in Cardiovascular Medicine.2020;[Epub]     CrossRef
  • The possible role of endocrine dysfunction of adipose tissue in gestational diabetes mellitus
    Patrik Šimják, Kateřina Anderlová, Anna Cinkajzlová, Antonín Pařízek, Michal Kršek, Martin Haluzík
    Minerva Endocrinologica.2020;[Epub]     CrossRef
  • High Plasma Resistin Levels Portend the Insulin Resistance-Associated Susceptibility to Early Cognitive Decline in Patients with Type 2 Diabetes Mellitus
    Chenchen Wang, Xi Huang, Sai Tian, Rong Huang, Dan Guo, Hongyan Lin, Jiaqi Wang, Shaohua Wang
    Journal of Alzheimer's Disease.2020; 75(3): 807.     CrossRef
  • Resistin in metabolism, inflammation, and disease
    Deeksha Tripathi, Sashi Kant, Saurabh Pandey, Nasreen Z. Ehtesham
    The FEBS Journal.2020; 287(15): 3141.     CrossRef
  • Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases
    Lucia Recinella, Giustino Orlando, Claudio Ferrante, Annalisa Chiavaroli, Luigi Brunetti, Sheila Leone
    Frontiers in Physiology.2020;[Epub]     CrossRef
  • Correlation of CCL18 with Levels of Adi-pokines in the Sera of Patients with Myocardial Infarction in a 6-Month Period: Case Series
    Atefeh GamarTalepoor, Ehsan Dowlatshahi, Mehrnoush Doroudchi
    Iranian South Medical Journal.2020; 23(3): 222.     CrossRef
  • The Mesentery, Systemic Inflammation, and Crohn’s Disease
    Edgardo D Rivera, John Calvin Coffey, Dara Walsh, Eli D Ehrenpreis
    Inflammatory Bowel Diseases.2019; 25(2): 226.     CrossRef
  • Resistin and adenylyl cyclase-associated protein 1 (CAP1) regulate the expression of genes related to insulin resistance in BNL CL.2 mouse liver cells
    Dimiter Avtanski, Karin Chen, Leonid Poretsky
    Data in Brief.2019; 25: 104112.     CrossRef
  • Proteomic profile of patients with atrial fibrillation undergoing cardiac surgery†
    Ilias P Doulamis, George Samanidis, Aspasia Tzani, Asier Antoranz, Anastasios Gkogkos, Panagiotis Konstantopoulos, Vaia Pliaka, Angeliki Minia, Leonidas G Alexopoulos, Despina N Perrea, Konstantinos Perreas
    Interactive CardioVascular and Thoracic Surgery.2019; 28(1): 94.     CrossRef
  • Angiotensin-(1-7), Adipokines and Inflammation
    Deborah de Farias Lelis, Daniela Fernanda de Freitas, Amanda Souto Machado, Thaísa Soares Crespo, Sérgio Henrique Sousa Santos
    Metabolism.2019; 95: 36.     CrossRef
  • New Insights into Adipokines as Potential Biomarkers for Type-2 Diabetes Mellitus
    Marta Olivera-Santa Catalina, Pedro C. Redondo, Maria P. Granados, Carlos Cantonero, Jose Sanchez-Collado, Letizia Albarran, Jose J. Lopez
    Current Medicinal Chemistry.2019; 26(22): 4119.     CrossRef
  • Myokine–adipokine cross-talk: potential mechanisms for the association between plasma irisin and adipokines and cardiometabolic risk factors in Mexican children with obesity and the metabolic syndrome
    Adrian M. Gonzalez-Gil, Mariana Peschard-Franco, Elena C. Castillo, Gustavo Gutierrez-DelBosque, Victor Treviño, Christian Silva-Platas, Luisa Perez-Villarreal, Gerardo Garcia-Rivas, Leticia Elizondo-Montemayor
    Diabetology & Metabolic Syndrome.2019;[Epub]     CrossRef
  • Early Life Exposures to Perfluoroalkyl Substances in Relation to Adipokine Hormone Levels at Birth and During Childhood
    Colleen Shelly, Philippe Grandjean, Youssef Oulhote, Peter Plomgaard, Ruth Frikke-Schmidt, Flemming Nielsen, Denis Zmirou-Navier, Pal Weihe, Damaskini Valvi
    The Journal of Clinical Endocrinology & Metabolism.2019; 104(11): 5338.     CrossRef
  • Overweight and obesity in childhood: Dietary, biochemical, inflammatory and lifestyle risk factors
    Samah R. Albataineh, Eman F. Badran, Reema F. Tayyem
    Obesity Medicine.2019; 15: 100112.     CrossRef
  • Effects of major adipokines and the −420 C > G resistin gene polymorphism on the long-term outcome of patients with acute ischemic stroke
    Stella Bouziana, Konstantinos Tziomalos, Antonis Goulas, Timoleon-Achilleas Vyzantiadis, Maria Papadopoulou, Athanasia Panderi, Apostolos Ι. Ηatzitolios
    International Journal of Neuroscience.2019; 129(10): 978.     CrossRef
  • The Complex Interactions Between Obesity, Metabolism and the Brain
    Romina María Uranga, Jeffrey Neil Keller
    Frontiers in Neuroscience.2019;[Epub]     CrossRef
  • Resistin: A reappraisal
    E. Acquarone, F. Monacelli, R. Borghi, A. Nencioni, P. Odetti
    Mechanisms of Ageing and Development.2019; 178: 46.     CrossRef
  • Implications of resistin in type 2 diabetes mellitus and coronary artery disease: Impairing insulin function and inducing pro‐inflammatory cytokines
    Melissa Emamalipour, Khaled Seidi, Ali Jahanban‐Esfahlan, Rana Jahanban‐Esfahlan
    Journal of Cellular Physiology.2019; 234(12): 21758.     CrossRef
  • Serum-based soluble markers differentiate psoriatic arthritis from osteoarthritis
    Vinod Chandran, Fatima Abji, Anthony V Perruccio, Rajiv Gandhi, Suzanne Li, Richard J Cook, Dafna D Gladman
    Annals of the Rheumatic Diseases.2019; 78(6): 796.     CrossRef
  • Telmisartan prevents diet-induced obesity and preserves leptin transport across the blood-brain barrier in high-fat diet-fed mice
    Franziska Schuster, Gianna Huber, Ines Stölting, Emily E. Wing, Kathrin Saar, Norbert Hübner, William A. Banks, Walter Raasch
    Pflügers Archiv - European Journal of Physiology.2018; 470(11): 1673.     CrossRef
  • Adipokines in human breast milk
    Juergen Kratzsch, Yoon Ju Bae, Wieland Kiess
    Best Practice & Research Clinical Endocrinology & Metabolism.2018; 32(1): 27.     CrossRef
  • Addressing the Perfect Storm: Biomarkers in Obesity and Pathophysiology of Cardiometabolic Risk
    Krasimira Aleksandrova, Dariush Mozaffarian, Tobias Pischon
    Clinical Chemistry.2018; 64(1): 142.     CrossRef
  • Adipocytokine Involvement in Innate Immune Mechanisms
    Paulina Żelechowska, Elżbieta Kozłowska, Joanna Pastwińska, Justyna Agier, Ewa Brzezińska-Błaszczyk
    Journal of Interferon & Cytokine Research.2018; 38(12): 527.     CrossRef
  • The effect of a garlic supplement on the pro-inflammatory adipocytokines, resistin and tumor necrosis factor-alpha, and on pain severity, in overweight or obese women with knee osteoarthritis
    Sahar Dehghani, Elham Alipoor, Ahmad Salimzadeh, Mehdi Yaseri, Mostafa Hosseini, Christine Feinle-Bisset, Mohammad Javad Hosseinzadeh-Attar
    Phytomedicine.2018; 48: 70.     CrossRef
  • Perivascular adipose tissue (PVAT) in atherosclerosis: a double-edged sword
    Xiao-Yan Qi, Shun-Lin Qu, Wen-Hao Xiong, Oren Rom, Lin Chang, Zhi-Sheng Jiang
    Cardiovascular Diabetology.2018;[Epub]     CrossRef
  • Usefulness of the Adipokines as Biomarkers of Ischemic Cardiac Dysfunction
    Larisa-Diana Mocan Hognogi, Cerasela-Mihaela Goidescu, Anca-Daniela Farcaş
    Disease Markers.2018; 2018: 1.     CrossRef
  • Circulating fibroblast growth factor 21 in patients with liver cirrhosis
    Sabrina Krautbauer, Lisa Rein-Fischboeck, Elisabeth M Haberl, Rebekka Pohl, Reiner Wiest, Christa Buechler
    Clinical and Experimental Medicine.2018; 18(1): 63.     CrossRef
  • Association of Cord Blood Resistin with Neonatal Birth Weight and Gestational Age
    Shahnaz Pourarian, Saeed Fotouhikia, Forough Saki
    Journal of Comprehensive Pediatrics.2018;[Epub]     CrossRef
  • Major Adipokines and the −420C>G Resistin Gene Polymorphism as Predictors of Acute Ischemic Stroke Severity and In-Hospital Outcome
    Styliani D. Bouziana, Konstantinos Tziomalos, Antonios Goulas, Timoleon-Achilleas Vyzantiadis, Athanasia Panderi, Apostolos Ι. Ηatzitolios
    Journal of Stroke and Cerebrovascular Diseases.2018; 27(4): 963.     CrossRef
  • Resistin and NGAL are associated with inflammatory response, endothelial activation and clinical outcomes in sepsis
    Stephen P. J. Macdonald, Erika Bosio, Claire Neil, Glenn Arendts, Sally Burrows, Lisa Smart, Simon G. A. Brown, Daniel M. Fatovich
    Inflammation Research.2017; 66(7): 611.     CrossRef
  • Reference values for fasting serum resistin in healthy children and adolescents
    Ulrik Lausten-Thomsen, Michael Christiansen, Paula Louise Hedley, Tenna Ruest Haarmark Nielsen, Cilius Esmann Fonvig, Oluf Pedersen, Torben Hansen, Jens-Christian Holm
    Clinica Chimica Acta.2017; 469: 161.     CrossRef
  • Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis
    Alexander Kalinkovich, Gregory Livshits
    Ageing Research Reviews.2017; 35: 200.     CrossRef
  • Is There Any Relationship between Plasma 25-Hydroxyvitamin D3, Adipokine Profiles and Excessive Body Weight in Type 2 Diabetic Patients?
    Joanna Kocot, Piotr Dziemidok, Małgorzata Kiełczykowska, Jacek Kurzepa, Grzegorz Szcześniak, Irena Musik
    International Journal of Environmental Research and Public Health.2017; 15(1): 19.     CrossRef
  • Exogenous Adipokine Peptide Resistin Protects Against Focal Cerebral Ischemia/Reperfusion Injury in Mice
    Jiangtao Zhu, Di Wu, Chenyu Zhao, Man Luo, Ronald C. Hamdy, Balvin H. L. Chua, Xingshun Xu, Zhigang Miao
    Neurochemical Research.2017; 42(10): 2949.     CrossRef
  • Adipokines in Liver Cirrhosis
    Christa Buechler, Elisabeth Haberl, Lisa Rein-Fischboeck, Charalampos Aslanidis
    International Journal of Molecular Sciences.2017; 18(7): 1392.     CrossRef
  • The role of sex steroids in white adipose tissue adipocyte function
    A E Newell-Fugate
    Reproduction.2017; 153(4): R133.     CrossRef
  • Odanacatib Inhibits Resistin-induced Cardiomyocyte Hypertrophy Through the Inactivation of ERK Signaling Pathway
    Xian Zheng, Guanchang Cheng, Jianwei Luo, Qunhui Ye, Yongzhi Deng, Lin Wu
    International Journal of Pharmacology.2017; 13(2): 212.     CrossRef
  • Linking resistin, inflammation, and cardiometabolic diseases
    Hyeong Kyu Park, Mi Kyung Kwak, Hye Jeong Kim, Rexford S. Ahima
    The Korean Journal of Internal Medicine.2017; 32(2): 239.     CrossRef
  • Translating the biology of adipokines in atherosclerosis and cardiovascular diseases: Gaps and open questions
    M. Ruscica, A. Baragetti, A.L. Catapano, G.D. Norata
    Nutrition, Metabolism and Cardiovascular Diseases.2017; 27(5): 379.     CrossRef
  • Differences in Mean Levels of Maternal Resistin Serum between Early Onset Preeclampsia (EOPE) and Late Onset Preeclampsia (LOPE)
    Yusrawati ., P. Alfajra, R. Machmud
    Research Journal of Obstetrics and Gynecology.2016; 10(1): 1.     CrossRef
  • Secret talk between adipose tissue and central nervous system via secreted factors—an emerging frontier in the neurodegenerative research
    Avinash Parimisetty, Anne-Claire Dorsemans, Rana Awada, Palaniyandi Ravanan, Nicolas Diotel, Christian Lefebvre d’Hellencourt
    Journal of Neuroinflammation.2016;[Epub]     CrossRef
  • The role of adipokines in ischemic stroke risk stratification
    Styliani Bouziana, Konstantinos Tziomalos, Antonios Goulas, Apostolos Ι Ηatzitolios
    International Journal of Stroke.2016; 11(4): 389.     CrossRef
  • The endocrine function of human placenta: an overview
    Mariana A. Costa
    Reproductive BioMedicine Online.2016; 32(1): 14.     CrossRef
  • Ursolic acid plays a protective role in obesity-induced cardiovascular diseases
    Yu-Ting Lin, Ya-Mei Yu, Weng-Cheng Chang, Su-Yin Chiang, Hsu-Chin Chan, Ming-Fen Lee
    Canadian Journal of Physiology and Pharmacology.2016; 94(6): 627.     CrossRef
  • Determinants of body weight regulation in humans
    Milene Moehlecke, Luis Henrique Canani, Lucas Oliveira Junqueira e Silva, Manoel Roberto Maciel Trindade, Rogerio Friedman, Cristiane Bauermann Leitão
    Archives of Endocrinology and Metabolism.2016; 60(2): 152.     CrossRef
  • Sitagliptin decreases ventricular arrhythmias by attenuated glucose-dependent insulinotropic polypeptide (GIP)-dependent resistin signalling in infarcted rats
    Tsung-Ming Lee, Wei-Ting Chen, Nen-Chung Chang
    Bioscience Reports.2016;[Epub]     CrossRef
  • Les adipokines : état des lieux et nouveautés
    J.-P. Bastard, C. Bastard, S. Fellahi, C. Vatier, J. Capeau, B. Fève
    Obésité.2016; 11(3): 181.     CrossRef
  • Factors that promote macrophage homing to adipose tissue in metabolic syndrome
    Ishwarlal Jialal, Beverley Adams-Huet, Sridevi Devaraj
    Journal of Diabetes and its Complications.2016; 30(8): 1434.     CrossRef
  • Uncovering Factors Related to Pancreatic Beta-Cell Function
    Aoife M. Curran, Miriam F. Ryan, Elaine Drummond, Eileen R. Gibney, Michael J. Gibney, Helen M. Roche, Lorraine Brennan, Nigel Irwin
    PLOS ONE.2016; 11(8): e0161350.     CrossRef
  • Resistin’s, obesity and insulin resistance: the continuing disconnect between rodents and humans
    X. Huang, Z. Yang
    Journal of Endocrinological Investigation.2016; 39(6): 607.     CrossRef
  • Adipocytokines in renal transplant recipients
    Kristof Nagy, Shankar Prasad Nagaraju, Connie M. Rhee, Zoltan Mathe, Miklos Z. Molnar
    Clinical Kidney Journal.2016; 9(3): 359.     CrossRef
  • Endocrine alterations from concentric vs. eccentric muscle actions: A brief review
    Robert R. Kraemer, V. Daniel Castracane
    Metabolism.2015; 64(2): 190.     CrossRef
  • Non-traditional cytokines: How catecholamines and adipokines influence macrophages in immunity, metabolism and the central nervous system
    Mark A. Barnes, Monica J. Carson, Meera G. Nair
    Cytokine.2015; 72(2): 210.     CrossRef
  • Local and serum levels of adipokines in patients with obesity after periodontal therapy: one‐year follow‐up
    Tiago Eduardo Dias Gonçalves, Glaucia Santos Zimmermann, Luciene Cristina Figueiredo, Monique de Carvalho Souza, Daniele Ferreira da Cruz, Marta Ferreira Bastos, Hélio Doyle Pereira da Silva, Poliana Mendes Duarte
    Journal of Clinical Periodontology.2015; 42(5): 431.     CrossRef
  • Newborn Adipokines and Birth Outcomes
    Edwina H. Yeung, Alexander C. McLain, Nancy Anderson, David Lawrence, Nansi S. Boghossian, Charlotte Druschel, Erin Bell
    Paediatric and Perinatal Epidemiology.2015; 29(4): 317.     CrossRef
  • The effect of a preparation of minerals, vitamins and trace elements on the cardiac gene expression pattern in male diabetic rats
    Márta Sárközy, Gergő Szűcs, Márton Pipicz, Ágnes Zvara, Katalin Éder, Veronika Fekete, Csilla Szűcs, Judit Bárkányi, Csaba Csonka, László G. Puskás, Csaba Kónya, Péter Ferdinandy, Tamás Csont
    Cardiovascular Diabetology.2015;[Epub]     CrossRef
  • Diet-induced variability of the resistin gene (Retn) transcript level and methylation profile in rats
    Joanna Nowacka-Woszuk, Ewa Pruszynska-Oszmalek, Maciej Szydlowski, Slawomir Sadkowski, Izabela Szczerbal
    BMC Genetics.2015;[Epub]     CrossRef
  • INFLUENCE OF RESISTIN ON THE COURSE OF ISCHEMIC HEART DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    A. T. Teplyakov, Sh. D. Akhmedov, T. Ye. Suslova, А. V. Andriyanova, A. V. Kuznetsova, N. V. Protopopova, V. V. Kalyuzhin, O. N. Nasanova
    Bulletin of Siberian Medicine.2015; 14(5): 73.     CrossRef
  • The Effects of a Single Developmentally Entrained Pulse of Testosterone in Female Neonatal Mice on Reproductive and Metabolic Functions in Adult Life
    Hyeran Jang, Shalender Bhasin, Tyler Guarneri, Carlo Serra, Mary Schneider, Mi-Jeong Lee, Wen Guo, Susan K. Fried, Karol Pencina, Ravi Jasuja
    Endocrinology.2015; 156(10): 3737.     CrossRef
  • The Resin fromProtium heptaphyllumPrevents High-Fat Diet-Induced Obesity in Mice: Scientific Evidence and Potential Mechanisms
    Karine Maria Martins Bezerra Carvalho, José Delano Barreto Marinho Filho, Tiago Sousa de Melo, Ana Jérsia Araújo, Josiane da Silva Quetz, Maria do Perpétuo Socorro Saldanha da Cunha, Karina Moura de Melo, Armenio Andre de Carvalho Almeida da Silva, Adrian
    Evidence-Based Complementary and Alternative Medicine.2015; 2015: 1.     CrossRef
  • Evolution of the Vertebrate Resistin Gene Family
    Qingda Hu, Huanran Tan, David M. Irwin, Marc Robinson-Rechavi
    PLOS ONE.2015; 10(6): e0130188.     CrossRef
  • Obesity, adipokines and neuroinflammation
    Argel Aguilar-Valles, Wataru Inoue, Christoph Rummel, Giamal N. Luheshi
    Neuropharmacology.2015; 96: 124.     CrossRef
  • Adipokines at the crossroad between obesity and cardiovascular disease
    Filippo Molica, Sandrine Morel, Brenda Kwak, Françoise Rohner-Jeanrenaud, Sabine Steffens
    Thrombosis and Haemostasis.2015; 113(03): 553.     CrossRef
  • Resistin – 420 C/G polymorphism and serum resistin level in Iranian patients with gestational diabetes mellitus
    Mohammad Ali Takhshid, Zinab Zare
    Journal of Diabetes & Metabolic Disorders.2015;[Epub]     CrossRef
  • Ictal adipokines are associated with pain severity and treatment response in episodic migraine
    Nu Cindy Chai, Bizu Gelaye, Gretchen E. Tietjen, Paul D. Dash, Barbara A. Gower, Linda W. White, Thomas N. Ward, Ann I. Scher, B. Lee Peterlin
    Neurology.2015; 84(14): 1409.     CrossRef
  • Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegeneration
    Lindsay J. Spielman, Jonathan P. Little, Andis Klegeris
    Journal of Neuroimmunology.2014; 273(1-2): 8.     CrossRef
  • Wild Blueberries (Vaccinium myrtillus) Alleviate Inflammation and Hypertension Associated with Developing Obesity in Mice Fed with a High-Fat Diet
    Otto T. Mykkänen, Anne Huotari, Karl-Heinz Herzig, Thomas W. Dunlop, Hannu Mykkänen, Pirkka V. Kirjavainen, Michael Müller
    PLoS ONE.2014; 9(12): e114790.     CrossRef
  • Role of fat and adipokines in intestinal inflammation
    LeaI Kredel, Arvind Batra, Britta Siegmund
    Current Opinion in Gastroenterology.2014; 30(6): 559.     CrossRef
  • 13C metabolic flux analysis shows that resistin impairs the metabolic response to insulin in L6E9 myotubes
    Shirley Guzmán, Silvia Marin, Anibal Miranda, Vitaly A Selivanov, Josep J Centelles, Romain Harmancey, Fatima Smih, Annie Turkieh, Yves Durocher, Antonio Zorzano, Philippe Rouet, Marta Cascante
    BMC Systems Biology.2014;[Epub]     CrossRef
  • Bee Pollen Improves Muscle Protein and Energy Metabolism in Malnourished Old Rats through Interfering with the Mtor Signaling Pathway and Mitochondrial Activity
    Jérôme Salles, Nicolas Cardinault, Véronique Patrac, Alexandre Berry, Christophe Giraudet, Marie-Laure Collin, Audrey Chanet, Camille Tagliaferri, Philippe Denis, Corinne Pouyet, Yves Boirie, Stéphane Walrand
    Nutrients.2014; 6(12): 5500.     CrossRef
Diabetogenic Effect of Statins: A Double-Edged Sword?
Ji Sung Yoon, Hyoung Woo Lee
Diabetes Metab J. 2013;37(6):415-422.   Published online December 12, 2013
DOI: https://doi.org/10.4093/dmj.2013.37.6.415
  • 3,620 View
  • 43 Download
  • 16 Crossref
AbstractAbstract PDFPubReader   

Statins are widely prescribed cholesterol-lowering agents, which have been demonstrated to significantly reduce cardiovascular morbidity and mortality. However, recent trials have reported that statins cause worsening of hyperglycemia and increase the risk of new-onset diabetes. The association between the diabetogenic effect of statins with intensive dose and accompanying major risk factors for diabetes has been demonstrated. However, statins do not appear to have a class effect on insulin sensitivity in non-diabetic patients. Numerous mechanisms have been suggested to explain how statins cause β-cell insulin secretory dysfunction and peripheral insulin resistance leading to incident diabetes. According to findings from an aggregate of large clinical trials, the benefits of statin treatment appear to outweigh the risk of new-onset diabetes. Therefore, it would be inappropriate to discontinue the use of statins for prevention of cardiovascular events because of its potential risk for development of incident diabetes. This review addresses the currently available evidence related to statin use and new-onset diabetes from a clinical perspective.

Citations

Citations to this article as recorded by  
  • High doses of rosuvastatin induce impaired branched‐chain amino acid catabolism and lead to insulin resistance
    Xue Bai, Xingzhen Long, Fang Song, Baolin Chen, Changcheng Sheng, Cailin Tang, Li Li, Jiaxing Zhang, Rui Zhang, Jiquan Zhang, Jiali Li
    Experimental Physiology.2023; 108(7): 961.     CrossRef
  • Statins and the diabetogenic effect (II)
    Nicolae Bacinschi, Ina Guţu, Anastasia Caracaş, Svetlana Latuş, Stela Bacinschi-Gheorghiţă, Aurelia Bacinschi, Dumitru Ştîrba, Olesea Malancea
    Farmacist.ro.2022; 5(208): 14.     CrossRef
  • Statins and the diabetogenic effect (I)
    Nicolae Bacinschi, Ina Guţu, Anastasia Caracaş, Svetlana Latuş, Stela Bacinschi-Gheorghiţă, Aurelia Bacinschi, Dumitru Ştîrba, Olesea Malancea
    Farmacist.ro.2022; 4(207): 16.     CrossRef
  • Efficacy and Safety of a Fixed-Dose Combination of Candesartan and Rosuvastatin on Blood Pressure and Cholesterol in Patients With Hypertension and Hypercholesterolemia: A Multicenter, Randomized, Double-Blind, Parallel Phase III Clinical Study
    Kyoung Im Cho, Bo Hyun Kim, Yong Hyun Park, Jeong-Cheon Ahn, Sang Hyun Kim, Wook Jin Chung, Weon Kim, Il Suk Sohn, Jin Ho Shin, Yong Jin Kim, Kiyuk Chang, Cheol Woong Yu, Soe Hee Ahn, Seok Yeon Kim, Jae Kean Ryu, Jong Young Lee, Bum Kee Hong, Taek Jong Ho
    Clinical Therapeutics.2019; 41(8): 1508.     CrossRef
  • Change in ALT levels after administration of HMG‐CoA reductase inhibitors to subjects with pretreatment levels three times the upper normal limit in clinical practice
    Hyunah Kim, Hyeseon Lee, Tong Min Kim, So Jung Yang, Seo Yeon Baik, Seung‐Hwan Lee, Jae‐Hyoung Cho, Hyunyong Lee, Hyeon Woo Yim, In Young Choi, Kun‐Ho Yoon, Hun‐Sung Kim
    Cardiovascular Therapeutics.2018;[Epub]     CrossRef
  • Phenotyping of Korean patients with better-than-expected efficacy of moderate-intensity statins using tensor factorization
    Jingyun Choi, Yejin Kim, Hun-Sung Kim, In Young Choi, Hwanjo Yu, Katriina Aalto-Setala
    PLOS ONE.2018; 13(6): e0197518.     CrossRef
  • Management of patients with statin intolerance
    Sabine Fischer, Ulrich Julius
    Atherosclerosis Supplements.2017; 30: 33.     CrossRef
  • Use of Moderate‐Intensity Statins for Low‐Density Lipoprotein Cholesterol Level above 190 mg/dL at Baseline in Koreans
    Hun‐Sung Kim, Hyeseon Lee, Sue Hyun Lee, Yoo Jin Jeong, Tong Min Kim, So Jung Yang, Sun Jung Baik, Hyunah Kim, Seung‐Hwan Lee, Jae Hyoung Cho, In‐Young Choi, Kun‐Ho Yoon, Ju Han Kim
    Basic & Clinical Pharmacology & Toxicology.2017; 121(4): 272.     CrossRef
  • Uso de estatinas e o risco de Diabetes Mellitus tipo 2: Revisão Baseada na Evidência
    Susana Silva, Nuno Monteiro
    Revista Brasileira de Medicina de Família e Comunidade.2016; 11(38): 1.     CrossRef
  • Association of statin use and stress-induced hyperglycemia in patients with acute ST-elevation myocardial infarction
    Chen Yan, Ma Qin, Yang S Juan, Li Y Tao, Gao M dong, Zeng Zechun, Yang X Chun, Cong H Liang, Liu Yin, Meng Kang
    JRSM Cardiovascular Disease.2016; 5: 204800401663944.     CrossRef
  • Statin‐related aminotransferase elevation according to baseline aminotransferases level in real practice in Korea
    H.‐S. Kim, S. H. Lee, H. Kim, S.‐H. Lee, J. H. Cho, H. Lee, H. W. Yim, S.‐H. Kim, I.‐Y. Choi, K.‐H. Yoon, J. H. Kim
    Journal of Clinical Pharmacy and Therapeutics.2016; 41(3): 266.     CrossRef
  • Statins and their increased risk of inducing diabetes
    Aris P Agouridis, Michael S Kostapanos, Moses S Elisaf
    Expert Opinion on Drug Safety.2015; 14(12): 1835.     CrossRef
  • Effects ofVacciniumBerries on Serum Lipids: A Meta-Analysis of Randomized Controlled Trials
    Yitong Zhu, Ya Miao, Zheying Meng, Yuan Zhong
    Evidence-Based Complementary and Alternative Medicine.2015; 2015: 1.     CrossRef
  • Type 2 Diabetes Mellitus, Metabolic Syndrome, and Mixed Dyslipidemia: How Similar, How Different, and How to Treat?
    Julian Halcox, Anoop Misra
    Metabolic Syndrome and Related Disorders.2015; 13(1): 1.     CrossRef
  • How to balance cardiorenometabolic benefits and risks of statins
    Soo Lim, Pyung Chun Oh, Ichiro Sakuma, Kwang Kon Koh
    Atherosclerosis.2014; 235(2): 644.     CrossRef
  • Contemporary treatment strategies for Type 2 diabetes-related macrovascular disease
    Andrew MN Walker, Richard M Cubbon, Mark T Kearney
    Expert Review of Endocrinology & Metabolism.2014; 9(6): 641.     CrossRef
Clinical Marker of Platelet Hyperreactivity in Diabetes Mellitus
Jin Hwa Kim, Hak Yeon Bae, Sang Yong Kim
Diabetes Metab J. 2013;37(6):423-428.   Published online December 12, 2013
DOI: https://doi.org/10.4093/dmj.2013.37.6.423
  • 4,400 View
  • 52 Download
  • 26 Crossref
AbstractAbstract PDFPubReader   

Atherothrombotic complications are important causes of morbidity and mortality in diabetic patients. Diabetes has been considered to be a prothrombotic status. Several factors contribute to the prothrombotic condition, such as increasing coagulation, impaired fibrinolysis, endothelial dysfunction, and platelet hyperreactivity. Among the factors that contribute to the prothrombotic status in diabetes, altered platelet function plays a crucial role. Although understanding platelet function abnormalities in diabetes still remains as a challenge, more attention should be focused on platelet function for effective management and the prediction of atherothrombotic events in diabetic patients. This review will provide an overview on the current status of knowledge of platelet function abnormalities and clinical marker of platelet hyperreactivity in patients with diabetes.

Citations

Citations to this article as recorded by  
  • Prediction of type 2 diabetes mellitus using hematological factors based on machine learning approaches: a cohort study analysis
    Amin Mansoori, Toktam Sahranavard, Zeinab Sadat Hosseini, Sara Saffar Soflaei, Negar Emrani, Eisa Nazar, Melika Gharizadeh, Zahra Khorasanchi, Sohrab Effati, Mark Ghamsary, Gordon Ferns, Habibollah Esmaily, Majid Ghayour Mobarhan
    Scientific Reports.2023;[Epub]     CrossRef
  • Platelet P2Y1 receptor exhibits constitutive G protein signaling and β-arrestin 2 recruitment
    Agnès Ribes, Cédric Garcia, Marie-Pierre Gratacap, Evi Kostenis, Laurent O. Martinez, Bernard Payrastre, Jean-Michel Sénard, Céline Galés, Véronique Pons
    BMC Biology.2023;[Epub]     CrossRef
  • Sex differences in the relationship between platelet count and type 2 diabetes risk in community‐dwelling adults: Longitudinal findings over 14 years
    Eun Kyeong Yun, In‐Ho Seo, Hye Sun Lee, So‐Young Seol, Yong‐Jae Lee
    Diabetes/Metabolism Research and Reviews.2023;[Epub]     CrossRef
  • Platelet Glycoprotein-Ib (GPIb) May Serve as a Bridge between Type 2 Diabetes Mellitus (T2DM) and Atherosclerosis, Making It a Potential Target for Antiplatelet Agents in T2DM Patients
    Muttia Amalia, Meidi Utami Puteri, Fadlina Chany Saputri, Rani Sauriasari, Bambang Widyantoro
    Life.2023; 13(7): 1473.     CrossRef
  • Effect of oral versus parenteral vitamin D3 supplementation on nuclear factor-κB and platelet aggregation in type 2 diabetic patients
    Esraa Habiba, Samia Ali, Yehia Ghanem, Ola Sharaki, Wafaa Hewedy
    Canadian Journal of Physiology and Pharmacology.2023; 101(11): 610.     CrossRef
  • Characteristics of cerebral ischemic stroke based on moyamoya disease and atherosclerosis-associated intracranial arterial stenosis
    Zhiying Chen, Xiaoqin Wu, Da Zhou, Shuling Shang, Yuchuan Ding, Xunming Ji, Ran Meng
    Neurological Sciences.2022; 43(2): 1087.     CrossRef
  • Basic Coagulation Profiles and Platelet Parameters Among Adult Type 1 and Type 2 Diabetes Patients at Dessie Referral Hospital, Northeast Ethiopia: Comparative Cross-Sectional Study
    Hussen Ebrahim, Fikir Asrie, Zegeye Getaneh
    Journal of Blood Medicine.2021; Volume 12: 33.     CrossRef
  • Magnetic fields as a potential therapy for diabetic wounds based on animal experiments and clinical trials
    Huanhuan Lv, Junyu Liu, Chenxiao Zhen, Yijia Wang, Yunpeng Wei, Weihao Ren, Peng Shang
    Cell Proliferation.2021;[Epub]     CrossRef
  • Diabetes and hypertension: Pivotal involvement of purinergic signaling
    Karine Paula Reichert, Milagros Fanny Vera Castro, Charles Elias Assmann, Nathieli Bianchin Bottari, Vanessa Valéria Miron, Andréia Cardoso, Naiara Stefanello, Vera Maria Melchiors Morsch, Maria Rosa Chitolina Schetinger
    Biomedicine & Pharmacotherapy.2021; 137: 111273.     CrossRef
  • The hemostatic parameters in pregnant women with different types of diabetes mellitus
    R. V. Kapustin, E. V. Kopteeva, O. N. Arzhanova, A. V. Tiselko, N. Е. Androsova, T. I. Oparina
    Diabetes mellitus.2021; 24(3): 251.     CrossRef
  • Comparison of the progressive changes in hemogram parameters of normal glycemic and gestational diabetic patients throughout the first two trimesters and predictive ability of these indices for gestational diabetes mellitus
    Pelin AYTAN, Seyran BOZKURT BABUŞ, Özde SAKARYA, Revan Sabri ÇİFTÇİ, Kasım AKAY, Hakan AYTAN
    Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi.2020; 17(4): 533.     CrossRef
  • A Pilot Study on the Effect of Anti-Thrombopoietin Antibody on Platelet Count in Patients with Type 2 Diabetes
    Takuya Fukuda, Masahide Hamaguchi, Takafumi Osaka, Yoshitaka Hashimoto, Emi Ushigome, Mai Asano, Masahiro Yamazaki, Eriko Fukuda, Kei Yamaguchi, Koji Ogawa, Naoki Goshima, Michiaki Fukui
    Molecules.2020; 25(7): 1667.     CrossRef
  • Patient with diabetes after acute coronary event. How to improve forecast?
    O. L. Barbarash
    Medical alphabet.2019; 1(3): 6.     CrossRef
  • Enhanced Platelet Sensitivity to IGF-1 in Patients with Type 2 Diabetes Mellitus
    N. Gligorijevic, D. Robajac, O. Nedic
    Biochemistry (Moscow).2019; 84(10): 1213.     CrossRef
  • Comprehensive Quality Control of the Regenerative Therapy Using Platelet Concentrates: The Current Situation and Prospects in Japan
    Tomoyuki Kawase, Kazuhiro Okuda
    BioMed Research International.2018; 2018: 1.     CrossRef
  • Changes in platelet morphology indices in relation to duration of disease and glycemic control in children with type 1 diabetes mellitus
    Vybhav Venkatesh, Rakesh Kumar, Dinesh Kumar Varma, Prateek Bhatia, Jaivinder Yadav, Devi Dayal
    Journal of Diabetes and its Complications.2018; 32(9): 833.     CrossRef
  • Quantifying Platelet Margination in Diabetic Blood Flow
    Hung-Yu Chang, Alireza Yazdani, Xuejin Li, Konstantinos A.A. Douglas, Christos S. Mantzoros, George Em Karniadakis
    Biophysical Journal.2018; 115(7): 1371.     CrossRef
  • Redox Proteomics and Platelet Activation: Understanding the Redox Proteome to Improve Platelet Quality for Transfusion
    Giona Sonego, Mélanie Abonnenc, Jean-Daniel Tissot, Michel Prudent, Niels Lion
    International Journal of Molecular Sciences.2017; 18(2): 387.     CrossRef
  • Farnesoid X Receptor and Liver X Receptor Ligands Initiate Formation of Coated Platelets
    Amanda J. Unsworth, Alexander P. Bye, Dionne S. Tannetta, Michael J.R. Desborough, Neline Kriek, Tanya Sage, Harriet E. Allan, Marilena Crescente, Parveen Yaqoob, Timothy D. Warner, Chris I. Jones, Jonathan M. Gibbins
    Arteriosclerosis, Thrombosis, and Vascular Biology.2017; 37(8): 1482.     CrossRef
  • Aspirin in the prevention of cardiovascular events in patients with diabetes
    David S. H. Bell
    Postgraduate Medicine.2016; 128(2): 180.     CrossRef
  • ROLE OF NITRIC OXIDE METABOLITES WITHIN THE IMPACT OF THE SUB-TOXIC SUCCINAMIDES DOSES ON STATE OF HEMOSTASIS
    I.А. Palagina, M.Y. Kudria, О.S. Lаlymеnkо
    Fiziolohichnyĭ zhurnal.2016; 62(6): 34.     CrossRef
  • Influence of genetic variations in platelet glycoproteins and eNOS in the development of arterial ischaemia of lower limbs in type 2 diabetes mellitus patients
    Virginia Carvalhais, Ema Ruivães, Luis Bernardo Pina-Cabral, Bárbara Mesquita, Flávio Oliveira, Maria Céu Monteiro, Maria Begoña Criado
    The Foot.2016; 29: 42.     CrossRef
  • Circulating endothelial progenitor cells and angiogenic factors in diabetes complicated diabetic foot and without foot complications
    Arleta Kulwas, Ewelina Drela, Wiesław Jundziłł, Barbara Góralczyk, Barbara Ruszkowska-Ciastek, Danuta Rość
    Journal of Diabetes and its Complications.2015; 29(5): 686.     CrossRef
  • Cerebrovascular diseases: perspectives of pathogenetic metabolic haemangiocorrective treatment
    M. M. Tanashyan, O. V. Lagoda, K. V. Antonova
    Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2015; 115(9): 70.     CrossRef
  • Letter: Clinical Marker of Platelet Hyperreactivity in Diabetes Mellitus (Diabetes Metab J2013;37:423-8)
    Cengiz Beyan, Esin Beyan
    Diabetes & Metabolism Journal.2014; 38(2): 158.     CrossRef
  • Response: Clinical Marker of Platelet Hyperreactivity in Diabetes Mellitus (Diabetes Metab J2013;37:423-8)
    Jin Hwa Kim, Hak Yeon Bae, Sang Yong Kim
    Diabetes & Metabolism Journal.2014; 38(2): 160.     CrossRef
Editorial
Metformin Based Dual-Combination Therapies in Drug Naïve Type 2 Diabetic Patients
Dong-Lim Kim
Diabetes Metab J. 2013;37(6):429-432.   Published online December 12, 2013
DOI: https://doi.org/10.4093/dmj.2013.37.6.429
  • 2,945 View
  • 30 Download
  • 3 Crossref
PDFPubReader   

Citations

Citations to this article as recorded by  
  • Association between Metformin Use and Risk of Lactic Acidosis or Elevated Lactate Concentration in Type 2 Diabetes
    Eun Young Lee, Sena Hwang, Yong-ho Lee, Seo Hee Lee, Young Mi Lee, Hua Pyong Kang, Eugene Han, Woonhyoung Lee, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
    Yonsei Medical Journal.2017; 58(2): 312.     CrossRef
  • Initial Combination Therapy With Canagliflozin Plus Metformin Versus Each Component as Monotherapy for Drug-Naïve Type 2 Diabetes
    Julio Rosenstock, Leonard Chuck, Manuel González-Ortiz, Kate Merton, Jagriti Craig, George Capuano, Rong Qiu
    Diabetes Care.2016; 39(3): 353.     CrossRef
  • Cardioprotective effect of concomitant administration of trigonelline and sitagliptin on cardiac biomarkers, lipid levels, electrocardiographic and heamodynamic modulation on cardiomyopathy in diabetic Wistar rats
    Hemant V. Kamble, Subhash L. Bodhankar
    Biomedicine & Aging Pathology.2014; 4(4): 335.     CrossRef
Original Articles
Prevalence and Management of Dyslipidemia in Korea: Korea National Health and Nutrition Examination Survey during 1998 to 2010
Eun Roh, Seung-Hyun Ko, Hyuk-Sang Kwon, Nan Hee Kim, Jae Hyeon Kim, Chul Sik Kim, Kee-Ho Song, Jong Chul Won, Dae Jung Kim, Sung Hee Choi, Soo Lim, Bong-Yun Cha
Diabetes Metab J. 2013;37(6):433-449.   Published online December 12, 2013
DOI: https://doi.org/10.4093/dmj.2013.37.6.433
  • 5,135 View
  • 39 Download
  • 73 Crossref
AbstractAbstract PDFPubReader   
Background

Dyslipidemia is a major risk factor of cardiovascular disease. The aim of this study was to investigate the changing trends in the prevalence and management status of dyslipidemia among Korean adults.

Methods

The prevalence of dyslipidemia and the rates of awareness, treatment, and control of dyslipidemia were investigated in adults aged ≥20 years from the Korea National Health and Nutrition Surveys (KNHANES) 1998 to 2010. The updated National Cholesterol Education Program criteria was used, which define dyslipidemia as having one or more of the following lipid abnormalities: hypercholesterolemia (total cholesterol ≥240 mg/dL or diagnosis of dyslipidemia or use of lipid-lowering drugs), hypertriglyceridemia (≥150 mg/dL), hyper-low density lipoprotein (LDL) cholesterolemia (≥160 mg/dL or diagnosis of dyslipidemia or use of lipid-lowering drugs), and hypo-high density lipoprotein (HDL)-cholesterolemia (<40 mg/dL in men and <50 mg/dL in women).

Results

The number of participants was 6,921, 4,894, 5,312, 2,733, 6,295, 6,900, and 5,738 in KNHANES 1998, 2001, 2005, 2007, 2008, 2009, and 2010, respectively. Age-standardized prevalence rates of dyslipidemia were 54.0%, 65.8%, 66.5%, 60.6%, 58.7%, 58.9%, and 59.0% in 1998, 2001, 2005, 2007, 2008, 2009, and 2010, respectively. Hypertriglyceridemia and hypo-HDL-cholesterolemia were the two most frequent lipid abnormalities. The overall prevalence of hypercholesterolemia and hyper-LDL-cholesterolemia increased by 1.36- and 1.35-fold in 2010 compared with 2007, respectively. Awareness, treatment, and control rates of dyslipidemia improved over the period of surveys in both sexes. In 2010, about 30% of dyslipidemic patients who received lipid-lowering treatment reached target levels.

Conclusion

Although the management status of dyslipidemia has improved during recent years, effective strategy is required for achieving better prevention, treatment, and control of dyslipidemia.

Citations

Citations to this article as recorded by  
  • SCORE and SCORE2 in East Asian Population
    JungMin Choi, Soseul Sung, Sue K. Park, Seyong Park, Hyoyeong Kim, Myeong-Chan Cho, Bryan Williams, Hae-Young Lee
    JACC: Asia.2024; 4(4): 265.     CrossRef
  • Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort data
    Dong Hyun Sinn, Danbee Kang, Yewan Park, Hyunsoo Kim, Yun Soo Hong, Juhee Cho, Geum-Youn Gwak
    BMC Gastroenterology.2023;[Epub]     CrossRef
  • Menopause management: A manual for primary care practitioners and nurse practitioners
    Neelam Aggarwal, Meeta Meeta, Nirja Chawla
    Journal of Mid-life Health.2022; 13(5): 2.     CrossRef
  • New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
    Kyuho Kim, Henry N. Ginsberg, Sung Hee Choi
    Diabetes & Metabolism Journal.2022; 46(4): 517.     CrossRef
  • Status of dyslipidemia management and statin undertreatment in Korean cancer survivors: A Korean National Health and Nutrition Examination Survey study
    Sujeong Shin, Dong Wook Shin, In Young Cho, Su-Min Jeong, Hyein Jung
    European Journal of Preventive Cardiology.2021; 28(8): 864.     CrossRef
  • Triglyceride glucose (TyG) index as a predictor of incident type 2 diabetes among nonobese adults: a 12-year longitudinal study of the Korean Genome and Epidemiology Study cohort
    Byoungjin Park, Hye Sun Lee, Yong-Jae Lee
    Translational Research.2021; 228: 42.     CrossRef
  • Temporal change in the diagnosis and treatment rates of osteoporosis: results from the Korea National Health and Nutrition Examination Survey
    Y. J. Choi, H.-B. Shin, B. Park, D. J. Kim, Y.-S. Chung
    Osteoporosis International.2021; 32(9): 1777.     CrossRef
  • Hypertriglyceridemia and Other Plasma Lipid Profile Abnormalities among People Living with Diabetes Mellitus in Ethiopia: A Systematic Review and Meta-Analysis
    Baye Dagnew, Yigizie Yeshaw, Demeke Geremew, Dessie Abebaw Angaw, Henok Dagne, Mekuriaw Alemayehu, Meseret Derbew Molla, Yonas Akalu, Carlos R. Bueno Junior
    BioMed Research International.2021; 2021: 1.     CrossRef
  • Triglyceride to HDL-Cholesterol Ratio and the Incident Risk of Ischemic Heart Disease Among Koreans Without Diabetes: A Longitudinal Study Using National Health Insurance Data
    Byoungjin Park, Dong Hyuk Jung, Hye Sun Lee, Yong Jae Lee
    Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
  • Three Musketeers for Lowering Cholesterol: Statins, Ezetimibe and Evolocumab
    Qian Xu, Yiming Deng, Jun Xiao, Xiangrui Liu, Min Zhou, Zhong Ren, Juan Peng, Yaling Tang, Zhisheng Jiang, Zhihan Tang, Lushan Liu
    Current Medicinal Chemistry.2021; 28(5): 1025.     CrossRef
  • Achievement of LDL-C Targets Defined by ESC/EAS (2011) Guidelines in Risk-Stratified Korean Patients with Dyslipidemia Receiving Lipid-Modifying Treatments
    Ye Seul Yang, Seo Young Lee, Jung-Sun Kim, Kyung Mook Choi, Kang Wook Lee, Sang-Chol Lee, Jung Rae Cho, Seung-Jin Oh, Ji-Hyun Kim, Sung Hee Choi
    Endocrinology and Metabolism.2020; 35(2): 367.     CrossRef
  • Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
    Myung Ji Goh, Dong Hyun Sinn, Seonwoo Kim, Sook Young Woo, Hyun Cho, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
    Hepatology.2020; 71(6): 2023.     CrossRef
  • Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study
    Ye Seul Yang, Bo Ram Yang, Mi-Sook Kim, Yunji Hwang, Sung Hee Choi
    Lipids in Health and Disease.2020;[Epub]     CrossRef
  • Prevalencia de hipertrigliceridemia en adultos y factores cardiometabólicos asociados. Estudio SIMETAP-HTG
    Antonio Ruiz-García, Ezequiel Arranz-Martínez, Beatriz López-Uriarte, Montserrat Rivera-Teijido, David Palacios-Martínez, Gema M. Dávila-Blázquez, Antonio Rosillo-González, José Antonio González-Posada Delgado, José Enrique Mariño-Suárez, Enrique Revilla-
    Clínica e Investigación en Arteriosclerosis.2020; 32(6): 242.     CrossRef
  • The Effect of High Carbohydrate-to-fat Intake Ratios on Hypo-HDL-cholesterolemia Risk and HDL-cholesterol Levels over a 12-year Follow-up
    Hye Ah Lee, Hyoin An
    Scientific Reports.2020;[Epub]     CrossRef
  • Design and rationale of a randomized control trial testing the effectiveness of combined therapy with STAtin plus FENOfibrate and statin alone in non-diabetic, combined dyslipidemia patients with non-intervened intermediate coronary artery disease - STAFE
    Taek-Geun Kwon, Albert Youngwoo Jang, Sang Wook Kim, Young Joon Hong, Jang-Ho Bae, Sung Yun Lee, Sang-Hyun Kim, Seung Hwan Han
    Trials.2020;[Epub]     CrossRef
  • Small-area variation  of cardiovascular diseases and select risk factors and their association to household and area poverty in South Africa: Capturing emerging trends in South Africa to better target local level interventions
    Ntabozuko Dwane, Njeri Wabiri, Samuel Manda, David Watkins
    PLOS ONE.2020; 15(4): e0230564.     CrossRef
  • Comprehensive Identification of Key Genes Involved in Development of Diabetes Mellitus-Related Atherogenesis Using Weighted Gene Correlation Network Analysis
    Qi Huang, Guoxiong Deng, Rongguo Wei, Qiaoye Wang, Donghua Zou, Jinru Wei
    Frontiers in Cardiovascular Medicine.2020;[Epub]     CrossRef
  • The triglyceride-glucose index predicts ischemic heart disease risk in Koreans: a prospective study using National Health Insurance Service data
    Byoungjin Park, Yong-Jae Lee, Hye Sun Lee, Dong-Hyuk Jung
    Cardiovascular Diabetology.2020;[Epub]     CrossRef
  • Prevalence of hypertriglyceridemia in adults and related cardiometabolic factors. SIMETAP-HTG study
    Antonio Ruiz-García, Ezequiel Arranz-Martínez, Beatriz López-Uriarte, Montserrat Rivera-Teijido, David Palacios-Martínez, Gema M. Dávila-Blázquez, Antonio Rosillo-González, José Antonio González-Posada Delgado, José Enrique Mariño-Suárez, Enrique Revilla-
    Clínica e Investigación en Arteriosclerosis (English Edition).2020; 32(6): 242.     CrossRef
  • Incident cardiovascular disease and particulate matter air pollution in South Korea using a population-based and nationwide cohort of 0.2 million adults
    Ok-Jin Kim, Soo Hyun Lee, Si-Hyuck Kang, Sun-Young Kim
    Environmental Health.2020;[Epub]     CrossRef
  • The association between low frequency of having breakfast and dyslipidemia in South Korean men and women
    Doo Woong Lee, Dong-Woo Choi, Yeong Jun Ju, Sang Ah Lee, Eun-Cheol Park
    European Journal of Clinical Nutrition.2019; 73(6): 896.     CrossRef
  • Estimated glycemic load (eGL) of mixed meals and its associations with cardiometabolic risk factors among Korean adults: data from the 2013 ~ 2016 Korea National Health and Nutrition Examination Survey
    Kyungho Ha, Kisun Nam, YoonJu Song
    Journal of Nutrition and Health.2019; 52(4): 354.     CrossRef
  • Working hours and nonalcoholic fatty liver disease according to sleep duration
    Hwanjin Park, Soo-Jin Lee
    Chronobiology International.2019; 36(12): 1671.     CrossRef
  • An analysis of the associations between gender and metabolic syndrome components in Korean adults: a national cross-sectional study
    Young-Mo Yang, Byung-Cheul Shin, Chihyoung Son, In-Hyuk Ha
    BMC Endocrine Disorders.2019;[Epub]     CrossRef
  • Time‐ and Dose‐Dependent Association of Statin Use With Risk of Clinically Relevant New‐Onset Diabetes Mellitus in Primary Prevention: A Nationwide Observational Cohort Study
    Min Jung Ko, Ae Jeong Jo, Yun Jung Kim, Shin Hee Kang, Songhee Cho, Sang‐Ho Jo, Cheol‐Young Park, Sung‐Cheol Yun, Woo Je Lee, Duk‐Woo Park
    Journal of the American Heart Association.2019;[Epub]     CrossRef
  • Dyslipidemia associated with body constitution in Traditional Chinese Medicine
    Qiuping Li, Qing Kong, Zihui Tang
    Traditional Medicine and Modern Medicine.2019; 02(02): 59.     CrossRef
  • Effect of Sulgidduk containing pine needle juice on lipid metabolism in high fat-cholesterol diet induced dyslipidemic rats
    Yunjung Lee, Jae-Hee Park, Eunju Park
    Journal of Nutrition and Health.2019; 52(1): 6.     CrossRef
  • Increased Serum Angiopoietin-Like 6 Ahead of Metabolic Syndrome in a Prospective Cohort Study
    Jun Namkung, Joon Hyung Sohn, Jae Seung Chang, Sang-Wook Park, Jang-Young Kim, Sang-Baek Koh, In Deok Kong, Kyu-Sang Park
    Diabetes & Metabolism Journal.2019; 43(4): 521.     CrossRef
  • Total cholesterol variability and risk of atrial fibrillation: A nationwide population-based cohort study
    Eun Roh, Hye Soo Chung, Ji Sung Lee, Jung A. Kim, You-Bin Lee, So-hyeon Hong, Nam Hoon Kim, Hye Jin Yoo, Ji A. Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Kyung Mook Choi, Stefan Kiechl
    PLOS ONE.2019; 14(4): e0215687.     CrossRef
  • Low Levels of Low-Density Lipoprotein Cholesterol and Mortality Outcomes in Non-Statin Users
    Sung, Huh, Ryu, Lee, Scorletti, Byrne, Kim, Hyun, Ko
    Journal of Clinical Medicine.2019; 8(10): 1571.     CrossRef
  • The differential effects of changes in individual macronutrient intake on changes in lipid concentrations during childhood: From the Ewha Birth & Growth Cohort
    Hye Ah Lee, Hyo Jeong Hwang, Se Young Oh, Eun Ae Park, Su Jin Cho, Hae Soon Kim, Hyesook Park
    Clinical Nutrition.2018; 37(3): 1027.     CrossRef
  • Association between cotinine‐verified smoking status and risk of nonalcoholic fatty liver disease
    Nam Hee Kim, Yoon Suk Jung, Hyun Pyo Hong, Jung Ho Park, Hong Joo Kim, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim
    Liver International.2018; 38(8): 1487.     CrossRef
  • The prevalence, awareness, and treatment of lipid abnormalities in Iranian adults: Surveillance of risk factors of noncommunicable diseases in Iran 2016
    Zahra Aryan, Negar Mahmoudi, Ali Sheidaei, Shahabeddin Rezaei, Zohreh Mahmoudi, Kimyia Gohari, Nazila Rezaei, Mohammad Javad Hajipour, Arezou Dilmaghani-Marand, Farideh Razi, Mahdi Sabooni, Farzad Kompani, Alireza Delavari, Bagher Larijani, Farshad Farzad
    Journal of Clinical Lipidology.2018; 12(6): 1471.     CrossRef
  • Low-carbohydrate diet and the risk of metabolic syndrome in Korean adults
    K. Ha, H. Joung, Y. Song
    Nutrition, Metabolism and Cardiovascular Diseases.2018; 28(11): 1122.     CrossRef
  • Association of change in total cholesterol level with mortality: A population-based study
    Su-Min Jeong, Seulggie Choi, Kyuwoong Kim, Sung-Min Kim, Gyeongsil Lee, Joung Sik Son, Jae-Moon Yun, Sang Min Park, Katriina Aalto-Setala
    PLOS ONE.2018; 13(4): e0196030.     CrossRef
  • Diabetes Fact Sheet in Korea, 2016: An Appraisal of Current Status
    Jong Chul Won, Jae Hyuk Lee, Jae Hyeon Kim, Eun Seok Kang, Kyu Chang Won, Dae Jung Kim, Moon-Kyu Lee
    Diabetes & Metabolism Journal.2018; 42(5): 415.     CrossRef
  • Evaluating the prevalence, awareness, and control of hypertension, diabetes, and dyslipidemia in Korea using the NHIS-NSC database
    Sunjoo Boo, Young Joo Yoon, Hyunjin Oh
    Medicine.2018; 97(51): e13713.     CrossRef
  • New and Future Parenteral Therapies for the Management of Lipid Disorders
    Roberto Garcia, Jaime Burkle
    Archives of Medical Research.2018; 49(8): 538.     CrossRef
  • Association between Dietary Pattern and Incidence of Cholesterolemia in Korean Adults: The Korean Genome and Epidemiology Study
    Jieul Lee, Jihye Kim
    Nutrients.2018; 10(1): 53.     CrossRef
  • Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled Trial
    Chee Hae Kim, Kyung Ah Han, Jaemyung Yu, Sang Hak Lee, Hui Kyung Jeon, Sang Hyun Kim, Seok Yeon Kim, Ki Hoon Han, Kyungheon Won, Dong-Bin Kim, Kwang-Jae Lee, Kyungwan Min, Dong Won Byun, Sang-Wook Lim, Chul Woo Ahn, SeongHwan Kim, Young Joon Hong, Jidong
    Clinical Therapeutics.2018; 40(1): 83.     CrossRef
  • Effects of Abdominal Obesity and Risk Drinking on the Hypertension Risk in Korean Adults
    Eun Sook Lee
    Journal of Korean Academy of Community Health Nursing.2018; 29(3): 349.     CrossRef
  • Does Adjuvant Treatment With Ginkgo Biloba to Statins Have Additional Benefits in Patients With Dyslipidemia?
    Yu Fan, Xin Jin, Changfeng Man, Dandan Gong
    Frontiers in Pharmacology.2018;[Epub]     CrossRef
  • Relationship with Smoking and Dyslipidemia in Korean Adults
    Dong Youl Shin, Young Keun Jang, Jae Hoon Lee, Jeong Hoon Wee, Dong Ho Chun
    Journal of the Korean Society for Research on Nicotine and Tobacco.2017; 8(2): 73.     CrossRef
  • Prevalence and Clinical Characteristics of Dyslipidemia in Koreans
    Jee-Sun Jeong, Hyuk-Sang Kwon
    Endocrinology and Metabolism.2017; 32(1): 30.     CrossRef
  • Management Status of Cardiovascular Disease Risk Factors for Dyslipidemia among Korean Adults
    Jongseok Lee, Heejeong Son, Ohk-Hyun Ryu
    Yonsei Medical Journal.2017; 58(2): 326.     CrossRef
  • Application of the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline to the Korean National Health and Nutrition Examination Surveys from 1998 to 2012
    Young Shin Song, Tae Jung Oh, Kyoung Min Kim, Jae Hoon Moon, Sung Hee Choi, Hak Chul Jang, Kyong Soo Park, Soo Lim
    Diabetes & Metabolism Journal.2017; 41(1): 38.     CrossRef
  • Dietary carbohydrate and fat intakes are differentially associated with lipid abnormalities in Korean adults
    SuJin Song, Won O. Song, YoonJu Song
    Journal of Clinical Lipidology.2017; 11(2): 338.     CrossRef
  • Metabolic Syndrome Causes Cardiovascular Disease under Stable Statin Medication
    Sang-Cheol Cho, Hoonhee Lee, Hyo-Jung Nam, Ki Hoon Han
    Journal of Lipid and Atherosclerosis.2017; 6(2): 75.     CrossRef
  • Improved trends in cardiovascular complications among subjects with type 2 diabetes in Korea: a nationwide study (2006–2013)
    Chang Hee Jung, Jin Ook Chung, Kyungdo Han, Seung-Hyun Ko, Kyung Soo Ko, Joong-Yeol Park
    Cardiovascular Diabetology.2017;[Epub]     CrossRef
  • Association Between the Awareness of Dyslipidemia and Health Behavior for Control of Lipid Levels Among Korean Adults with Dyslipidemia
    In Young Cho, Hwa Yeon Park, Kiheon Lee, Woo Kyung Bae, Se Young Jung, Hye Jin Ju, Jae Kyeong Song, Jong Soo Han
    Korean Journal of Family Medicine.2017; 38(2): 64.     CrossRef
  • Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case‐control study
    Gyuri Kim, Suk‐Yong Jang, Eugene Han, Yong‐ho Lee, Se‐young Park, Chung Mo Nam, Eun Seok Kang
    International Journal of Cancer.2017; 140(4): 798.     CrossRef
  • Association of dietary intakes of total and subtypes of fat substituted for carbohydrate with metabolic syndrome in Koreans
    Kyong Won Lee, Yoonsu Cho, Garam Jo, Yoo Kyoung Park, Min-Jeong Shin
    Endocrine Journal.2016; 63(11): 991.     CrossRef
  • Pre-treatment with simvastatin prevents the induction of diet-induced atherosclerosis in a rabbit model
    Nikolaos Oikonomidis, Nikolaos Kavantzas, Laskarina-Maria Korou, Panagiotis Konstantopoulos, Vasilios Pergialiotis, Evangelos Misiakos, Ioannis Rizos, Christos Verikokos, Despina N. Perrea
    Biomedical Reports.2016; 5(6): 667.     CrossRef
  • Comparative analysis of the efficacy of omega-3 fatty acids for hypertriglyceridaemia management in Korea
    H.-S. Kim, H. Kim, Y. J. Jeong, S. J. Yang, S. J. Baik, H. Lee, S.-H. Lee, J. H. Cho, I.-Y. Choi, H. W. Yim, K.-H. Yoon
    Journal of Clinical Pharmacy and Therapeutics.2016; 41(5): 508.     CrossRef
  • Parks and Green Areas Are Associated with Decreased Risk for Hyperlipidemia
    Hye-Jin Kim, Jin-Young Min, Hyun-Jin Kim, Kyoung-Bok Min
    International Journal of Environmental Research and Public Health.2016; 13(12): 1205.     CrossRef
  • Analysis and comparison of statin prescription patterns and outcomes according to clinical department
    H.-S. Kim, H. Kim, H. Lee, B. Park, S. Park, S.-H. Lee, J. H. Cho, H. Song, J. H. Kim, K.-H. Yoon, I. Y. Choi
    Journal of Clinical Pharmacy and Therapeutics.2016; 41(1): 70.     CrossRef
  • Dyslipidemia patterns are differentially associated with dietary factors
    SuJin Song, Hee Young Paik, Minseon Park, YoonJu Song
    Clinical Nutrition.2016; 35(4): 885.     CrossRef
  • Epidemiology of dyslipidemia in Korea
    Hyeon Chang Kim
    Journal of the Korean Medical Association.2016; 59(5): 352.     CrossRef
  • Difference between old and young adults in contribution of β‐cell function and sarcopenia in developing diabetes mellitus
    Bo Kyung Koo, Eun Roh, Ye Seul Yang, Min Kyong Moon
    Journal of Diabetes Investigation.2016; 7(2): 233.     CrossRef
  • Economic Evaluation of Rosuvastatin and Atorvastatin for the Treatment of Dyslipidemia from a Korean Health System Perspective
    Sunghwan Suh, Chang Hee Jung, Soon-Jun Hong, Jung-Sun Kim, Byung Ju Song, Hyun Soon Sohn, Sung Hee Choi
    Journal of Lipid and Atherosclerosis.2016; 5(1): 61.     CrossRef
  • Obesity and Hyperglycemia in Korean Men with Klinefelter Syndrome: The Korean Endocrine Society Registry
    Seung Jin Han, Kyung-Soo Kim, Wonjin Kim, Jung Hee Kim, Yong-ho Lee, Ji Sun Nam, Ji A Seo, Bu Kyung Kim, Jihyun Lee, Jin Ook Chung, Min-Hee Kim, Tae-Seo Sohn, Han Seok Choi, Seong Bin Hong, Yoon-Sok Chung
    Endocrinology and Metabolism.2016; 31(4): 598.     CrossRef
  • Effects of mulberry leaf extract on blood glucose and serum lipid profiles in patients with type 2 diabetes mellitus: A systematic review
    Seung-Ok Shin, Hyun-Ju Seo, Hyunyoung Park, Hyun Jin Song
    European Journal of Integrative Medicine.2016; 8(5): 602.     CrossRef
  • Diabetic Cardiovascular Autonomic Neuropathy Predicts Recurrent Cardiovascular Diseases in Patients with Type 2 Diabetes
    Seon-Ah Cha, Jae-Seung Yun, Tae-Seok Lim, Kyoungil Min, Ki-Ho Song, Ki-Dong Yoo, Yong-Moon Park, Yu-Bae Ahn, Seung-Hyun Ko, James M Wright
    PLOS ONE.2016; 11(10): e0164807.     CrossRef
  • Effects of Age, Sex, and Menopausal Status on Blood Cholesterol Profile in the Korean Population
    Ji Hye Park, Myung Ha Lee, Jee-Seon Shim, Dong Phil Choi, Bo Mi Song, Seung Won Lee, Hansol Choi, Hyeon Chang Kim
    Korean Circulation Journal.2015; 45(2): 141.     CrossRef
  • Is nutritional labeling associated with individual health? The effects of labeling-based awareness on dyslipidemia risk in a South Korean population
    Jong Yeob Kim, Ki Hong Kweon, Min Jae Kim, Eun-Cheol Park, Suk-Yong Jang, Woorim Kim, Kyu-Tae Han
    Nutrition Journal.2015;[Epub]     CrossRef
  • Cost-effectiveness analysis of low density lipoprotein cholesterol-lowering therapy in hypertensive patients with type 2 diabetes in Korea: single-pill regimen (amlodipine/atorvastatin) versus double-pill regimen (amlodipine+atorvastatin)
    Ji-Hyun Park, Yong-Ho Lee, Su-Kyoung Ko, Bong-Soo Cha
    Epidemiology and Health.2015; 37: e2015010.     CrossRef
  • Application of New Cholesterol Guidelines to the Korean Adult Diabetic Patients
    Bu Kyung Kim, Hyeon Chang Kim, Kyoung Hwa Ha, Dae Jung Kim
    Journal of Korean Medical Science.2015; 30(11): 1612.     CrossRef
  • Undiagnosed diabetes is prevalent in younger adults and associated with a higher risk cardiometabolic profile compared to diagnosed diabetes
    Yong-ho Lee, Ehrin J. Armstrong, Gyuri Kim, Jaewon Oh, Seok-Min Kang, Byung-Wan Lee, Chul Woo Ahn, Bong Soo Cha, Hyun Chul Lee, Christos S. Mantzoros, Eun Seok Kang
    American Heart Journal.2015; 170(4): 760.     CrossRef
  • New Drugs for Treating Dyslipidemia: Beyond Statins
    Chang Ho Ahn, Sung Hee Choi
    Diabetes & Metabolism Journal.2015; 39(2): 87.     CrossRef
  • Can increased visceral adiposity without body weight changes accelerate carotid atherosclerosis in South Korean participants with type 2 diabetes?
    Chul Sik Kim, Soo-Kyung Kim, Maria Rosario G. Araneta, Eun Jig Lee, Elizabeth Barrett-Connor, Kab Bum Huh
    Journal of Diabetes and its Complications.2015; 29(8): 1085.     CrossRef
  • Prevalence and Management of Dyslipidemia Among Korean Adults: KNHANES 2010-2012
    Sungok Jang, Jongseok Lee
    Journal of the Korea Academia-Industrial cooperation Society.2015; 16(11): 7978.     CrossRef
  • Prevalence and Gender-Related Characteristics of Metabolic Syndrome in Korean Community
    Kyung-Taek Park, Hack-Lyoung Kim, Sang-Hyun Kim, Myung-A Kim, Euijae Lee, Jonghanne Park, Sang-Ho Jo, Sung Rae Kim, Jaetaek Kim, Chee Jeong Kim, Moon-Kyu Lee, Hyun Ho Shin
    Journal of Lipid and Atherosclerosis.2014; 3(2): 89.     CrossRef
Subclinical Hypothyroidism Is Independently Associated with Microalbuminuria in a Cohort of Prediabetic Egyptian Adults
Mervat M. El-Eshmawy, Hala A. Abd El-Hafez, Walaa Othman El Shabrawy, Ibrahim A. Abdel Aal
Diabetes Metab J. 2013;37(6):450-457.   Published online December 12, 2013
DOI: https://doi.org/10.4093/dmj.2013.37.6.450
  • 3,275 View
  • 36 Download
  • 19 Crossref
AbstractAbstract PDFPubReader   
Background

Recent evidence has suggested an association between subclinical hypothyroidism (SCH) and microalbuminuria in patients with type 2 diabetes. However, whether SCH is related to microalbuminuria among subjects with prediabetes has not been studied. Thus, we evaluated the association between SCH and microalbuminuria in a cohort of prediabetic Egyptian adults.

Methods

A total of 147 prediabetic subjects and 150 healthy controls matched for age and sex were enrolled in this study. Anthropometric measurements, plasma glucose, lipid profile, homeostasis model assessment of insulin resistance (HOMA-IR), thyroid stimulating hormone (TSH), free thyroxine, triiodothyronine levels, and urinary albumin-creatinine ratio (UACR) were assessed.

Results

The prevalence of SCH and microalbuminuria in the prediabetic subjects was higher than that in the healthy controls (16.3% vs. 4%, P<0.001; and 12.9% vs. 5.3%, P=0.02, respectively). Prediabetic subjects with SCH were characterized by significantly higher HOMA-IR, TSH levels, UACR, and prevalence of microalbuminuria than those with euthyroidism. TSH level was associated with total cholesterol (P=0.05), fasting insulin (P=0.01), HOMA-IR (P=0.01), and UACR (P=0.005). UACR was associated with waist circumference (P=0.01), fasting insulin (P=0.05), and HOMA-IR (P=0.02). With multiple logistic regression analysis, SCH was associated with microalbuminuria independent of confounding variables (β=2.59; P=0.01).

Conclusion

Our findings suggest that prediabetic subjects with SCH demonstrate higher prevalence of microalbuminuria than their non-SCH counterparts. SCH is also independently associated with microalbuminuria in prediabetic subjects. Screening and treatment for SCH may be warranted in those patients.

Citations

Citations to this article as recorded by  
  • The prevalence of subclinical hypothyroidism in a pre-diabetes population and an analysis of related factors
    Xingyu Chang, Yaqi Wang, Yi Liu, Yanyu Shen, Jiaqing Feng, Qianqian Liu, Chenjun Jiang, Jing Yu, Xulei Tang, Gaojing Jing, Qianglong Niu, Songbo Fu
    Annals of Medicine.2023; 55(1): 643.     CrossRef
  • High Thyroid-Stimulating Hormone and Low Free Triiodothyronine Levels Are Associated with Chronic Kidney Disease in Three Population-Based Studies from Germany
    Till Ittermann, Sabrina von Rheinbaben, Marcello R. P. Markus, Marcus Dörr, Antje Steveling, Matthias Nauck, Alexander Teumer, Maik Gollasch, Dominik Spira, Maximilian König, Ilja Demuth, Elisabeth Steinhagen-Thiessen, Henry Völzke, Sylvia Stracke
    Journal of Clinical Medicine.2023; 12(17): 5763.     CrossRef
  • Free triiodothyronine predicts the risk of developing diabetic kidney disease
    Weihong Li, Zhi Yang, Shengjian Li, Shanshan Jiang, Wan Hu, Zhenying Wan, Ping Tu, Peng Duan
    BMC Nephrology.2023;[Epub]     CrossRef
  • The Correlation between Thyroid Hormone Levels and the Kidney Disease Progression Risk in Patients with Type 2 Diabetes
    Zhi Yang, Peng Duan, Weihong Li, Ronghui Nie, Xiaoyang Lou, Lina Wang, Kexia Wu, Jiang Liu, Ping Tu, Xiaoyang Lai
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 59.     CrossRef
  • Thyroid hormone status in patients with impaired kidney function
    Juliane Peters, Stefanos Roumeliotis, Peter R. Mertens, Vassilios Liakopoulos
    International Urology and Nephrology.2021; 53(11): 2349.     CrossRef
  • Subclinical hypothyroidism is associated with albuminuria in Japanese nondiabetic subjects
    Akiko Toda, Shigeko Hara, Hiroshi Tsuji, Yasuji Arase
    Endocrine.2020; 68(3): 592.     CrossRef
  • Hypothyroidism and Kidney Function: A Mendelian Randomization Study
    Christina Ellervik, Samia Mora, Paul M. Ridker, Daniel I. Chasman
    Thyroid.2020; 30(3): 365.     CrossRef
  • Relationship between serum thyrotropin and urine albumin excretion in euthyroid subjects with diabetes
    Gautam Das, Peter N Taylor, Hussam Abusahmin, Amer Ali, Brian P Tennant, John Geen, Onyebuchi Okosieme
    Annals of Clinical Biochemistry: International Journal of Laboratory Medicine.2019; 56(1): 155.     CrossRef
  • The longitudinal effect of subclinical hypothyroidism on urine microalbumin-to-urine creatinine ratio in patients with type 2 diabetes mellitus
    Juan Xie, Xiaoqing Wang, Yiyuan Zhang, Hailun Li, Yong Xu, Donghui Zheng
    BMC Endocrine Disorders.2019;[Epub]     CrossRef
  • The effect of l-thyroxine substitution on oxidative stress in early-stage diabetic nephropathy patients with subclinical hypothyroidism: a randomized double-blind and placebo-controlled study
    Yong Chen, Ganlin Wu, Meirong Xu
    International Urology and Nephrology.2018; 50(1): 97.     CrossRef
  • Association between subclinical hypothyroidism and diabetic nephropathy in type 2 diabetes
    Ayman Abd-Elrahman Mohamed Nsr-Allah, Azza H. Abd-El Fatah, Mahmoud Azab, Maggie M. Fawzi
    The Egyptian Journal of Internal Medicine.2018; 30(3): 160.     CrossRef
  • Role of Microalbuminuria in Predicting Cardiovascular Mortality in Individuals With Subclinical Hypothyroidism
    Tushar A. Tuliani, Maithili Shenoy, Kevin Belgrave, Abhishek Deshmukh, Sadip Pant, Anthony Hilliard, Luis Afonso
    The American Journal of the Medical Sciences.2017; 354(3): 285.     CrossRef
  • Inositol(s) in thyroid function, growth and autoimmunity
    Salvatore Benvenga, Alessandro Antonelli
    Reviews in Endocrine and Metabolic Disorders.2016; 17(4): 471.     CrossRef
  • Hypothyroïdie infra-clinique et risque d’évènements cardiovasculaires chez la femme diabétique de type 2
    M. Gourine, K. Bentadj, S. Mostefa-Kara, A. Cherrak, S. Halimi, M. Belhadj
    Médecine des Maladies Métaboliques.2016; 10(5): 466.     CrossRef
  • Can levothyroxine treatment reduce urinary albumin excretion rate in patients with early type 2 diabetic nephropathy and subclinical hypothyroidism? A randomized double-blind and placebo-controlled study
    Peng Liu, Ruidong Liu, Xia Chen, Yingying Chen, Debao Wang, Fengmei Zhang, Yangang Wang
    Current Medical Research and Opinion.2015; 31(12): 2233.     CrossRef
  • Free Triiodothyronine Levels Are Associated with Diabetic Nephropathy in Euthyroid Patients with Type 2 Diabetes
    Jingcheng Wu, Xiaohua Li, Yang Tao, Yufei Wang, Yongde Peng
    International Journal of Endocrinology.2015; 2015: 1.     CrossRef
  • Letter: Subclinical Hypothyroidism Is Independently Associated with Microalbuminuria in a Cohort of Prediabetic Egyptian Adults (Diabetes Metab J2013;37:450-7)
    In-Kyung Jeong
    Diabetes & Metabolism Journal.2014; 38(1): 83.     CrossRef
  • Free Triiodothyronine Concentrations Are Inversely Associated with Microalbuminuria
    Yulin Zhou, Lei Ye, Tiange Wang, Jie Hong, Yufang Bi, Jie Zhang, Baihui Xu, Jichao Sun, Xiaolin Huang, Min Xu
    International Journal of Endocrinology.2014; 2014: 1.     CrossRef
  • Thyroid hormone and heart failure: from myocardial protection to systemic regulation
    Laura Sabatino, Giorgio Iervasi, Alessandro Pingitore
    Expert Review of Cardiovascular Therapy.2014; 12(10): 1227.     CrossRef
Relative Skeletal Muscle Mass Is Associated with Development of Metabolic Syndrome
Byung Sam Park, Ji Sung Yoon
Diabetes Metab J. 2013;37(6):458-464.   Published online December 12, 2013
DOI: https://doi.org/10.4093/dmj.2013.37.6.458
  • 5,635 View
  • 104 Download
  • 73 Crossref
AbstractAbstract PDFPubReader   
Background

Visceral adiposity is related to insulin resistance. Skeletal muscle plays a central role in insulin-mediated glucose disposal; however, little is known about the association between muscle mass and metabolic syndrome (MS). This study is to clarify the clinical role of skeletal muscle mass in development of MS.

Methods

A total of 1,042 subjects were enrolled. Subjects with prior MS and chronic diseases were excluded. After 24 months, development of MS was assessed using NCEP-ATP III criteria. Skeletal muscle mass (SMM; kg), body fat mass (BFM; kg), and visceral fat area (VFA; cm2) were obtained from bioelectrical analysis. Then, the following values were calculated as follows: percent of SMM (SMM%; %): SMM (kg)/weight (kg), skeletal muscle index (SMI; kg/m2): SMM (kg)/height (m2), skeletal muscle to body fat ratio (MFR): SMM (kg)/BFM (kg), and skeletal muscle to visceral fat ratio (SVR; kg/cm2): SMM (kg)/VFA (cm2).

Results

Among 838 subjects, 88 (10.5%) were newly diagnosed with MS. Development of MS increased according to increasing quintiles of BMI, SMM, VFA, and SMI, but was negatively associated with SMM%, MFR, and SVR. VFA was positively associated with high waist circumference (WC), high blood pressure (BP), dysglycemia, and high triglyceride (TG). In contrast, MFR was negatively associated with high WC, high BP, dysglycemia, and high TG. SVR was negatively associated with all components of MS.

Conclusion

Relative SMM ratio to body composition, rather than absolute mass, may play a critical role in development of MS and could be used as a strong predictor.

Citations

Citations to this article as recorded by  
  • Relationship between adiponectin and muscle mass in patients with metabolic syndrome and obesity
    Daniel de Luis, David Primo, Olatz Izaola, Juan José Lopez Gomez
    Journal of Diabetes and its Complications.2024; 38(4): 108706.     CrossRef
  • The longitudinal association of adipose-to-lean ratio with incident cardiometabolic morbidity: The CARDIA study
    Robert Booker, Mandy Wong, Michael P. Bancks, Mercedes R. Carnethon, Lisa S. Chow, Cora E. Lewis, Pamela J. Schreiner, Shaina J. Alexandria
    Journal of Diabetes and its Complications.2024; 38(5): 108725.     CrossRef
  • Assessing Sarcopenic Obesity Risk in Children During the COVID-19 Pandemic: Grip-to-BMI Ratio
    Bahar Öztelcan Gündüz, Aysu Duyan Çamurdan, Mücahit Yıldız, F. Nur Baran Aksakal, Emine Nüket Ünsal
    Medical Research Reports.2024; 7(1): 18.     CrossRef
  • Sex differences in body composition in youth with type 1 diabetes and its predictive value in cardiovascular disease risk assessment
    Avivit Brener, Sandy Hamama, Hagar Interator, Asaf Ben Simon, Irina Laurian, Anna Dorfman, Efrat Chorna, Michal Yackobovitch‐Gavan, Asaf Oren, Ori Eyal, Yael Lebenthal
    Diabetes/Metabolism Research and Reviews.2023;[Epub]     CrossRef
  • Epidemiological, mechanistic, and practical bases for assessment of cardiorespiratory fitness and muscle status in adults in healthcare settings
    Jaime A. Gallo-Villegas, Juan C. Calderón
    European Journal of Applied Physiology.2023; 123(5): 945.     CrossRef
  • The Effect of Childhood Obesity or Sarcopenic Obesity on Metabolic Syndrome Risk in Adolescence: The Ewha Birth and Growth Study
    Hyunjin Park, Seunghee Jun, Hye-Ah Lee, Hae Soon Kim, Young Sun Hong, Hyesook Park
    Metabolites.2023; 13(1): 133.     CrossRef
  • Relationships of BMI, muscle-to-fat ratio, and handgrip strength-to-BMI ratio to physical fitness in Spanish children and adolescents
    Samuel Manzano-Carrasco, Jorge Garcia-Unanue, Eero A. Haapala, Jose Luis Felipe, Leonor Gallardo, Jorge Lopez-Fernandez
    European Journal of Pediatrics.2023; 182(5): 2345.     CrossRef
  • Body physique rating as a factor to identify at-risk Mexicans for Metabolic Syndrome
    Oscar Herrera-Fomperosa, Sergio K. Bustamante-Villagomez, Sarahí Vazquez-Álvarez, Gabriela Vázquez-Marroquín, Leonardo M. Porchia, Enrique Torres-Rasgado, Ricardo Pérez-Fuentes, M. Elba Gonzalez-Mejia
    Human Nutrition & Metabolism.2023; 33: 200206.     CrossRef
  • The association between creatinine to body weight ratio and the risk of progression to diabetes from pre-diabetes: a 5-year cohort study in Chinese adults
    Tong Li, Changchun Cao, Xuan Xuan, Wenjing Liu, Xiaohua Xiao, Cuimei Wei
    BMC Endocrine Disorders.2023;[Epub]     CrossRef
  • Muscle-to-Fat Ratio for Predicting Metabolic Syndrome Components in Children with Overweight and Obesity
    Noga Salton, Sharona Kern, Hagar Interator, Adar Lopez, Hadar Moran-Lev, Yael Lebenthal, Avivit Brener
    Childhood Obesity.2022; 18(2): 132.     CrossRef
  • Mentale Gesundheit und physische Aktivität
    Wolfgang Laube
    Manuelle Medizin.2022; 60(1): 13.     CrossRef
  • Increased odds of having the metabolic syndrome with greater fat‐free mass: counterintuitive results from the National Health and Nutrition Examination Survey database
    Jean‐Christophe Lagacé, Alexis Marcotte‐Chenard, Jasmine Paquin, Dominic Tremblay, Martin Brochu, Isabelle J. Dionne
    Journal of Cachexia, Sarcopenia and Muscle.2022; 13(1): 377.     CrossRef
  • Lipoprotein subfractions in patients with sarcopenia and their relevance to skeletal muscle mass and function
    Hui Gong, Yang Liu, Xing Lyu, Lini Dong, Xiangyu Zhang
    Experimental Gerontology.2022; 159: 111668.     CrossRef
  • Health Risks of Sarcopenic Obesity in Overweight Children and Adolescents: Data from the CHILT III Programme (Cologne)
    Carolin Sack, Nina Ferrari, David Friesen, Fabiola Haas, Marlen Klaudius, Lisa Schmidt, Gabriel Torbahn, Hagen Wulff, Christine Joisten
    Journal of Clinical Medicine.2022; 11(1): 277.     CrossRef
  • Creatinine-to-body weight ratio is a predictor of incident diabetes: a population-based retrospective cohort study
    Jiacheng He
    Diabetology & Metabolic Syndrome.2022;[Epub]     CrossRef
  • Relative low muscle mass and muscle strength is associated with the prevalence of metabolic syndrome in patients with type 2 diabetes
    Maya Takegami, Yoshitaka Hashimoto, Masahide Hamaguchi, Ayumi Kaji, Ryosuke Sakai, Takuro Okamura, Noriyuki Kitagawa, Takafumi Osaka, Hiroshi Okada, Naoko Nakanishi, Saori Majima, Takafumi Senmaru, Emi Ushigome, Mai Asano, Masahiro Yamazaki, Michiaki Fuku
    Journal of Clinical Biochemistry and Nutrition.2022; 71(2): 136.     CrossRef
  • “Big Data” Approaches for Prevention of the Metabolic Syndrome
    Xinping Jiang, Zhang Yang, Shuai Wang, Shuanglin Deng
    Frontiers in Genetics.2022;[Epub]     CrossRef
  • Teil 2: Muskeldysfunktionen – mit Training gegen Schmerz
    Wolfgang Laube
    Manuelle Medizin.2022; 60(3): 129.     CrossRef
  • Impact of Low Skeletal Muscle Mass and Obesity on Hearing Loss in Asymptomatic Individuals: A Population-Based Study
    Chul-Hyun Park, Kyung Jae Yoon, Yong-Taek Lee, Sung Min Jin, Sang Hyuk Lee, Tae Hwan Kim
    Healthcare.2022; 10(10): 2022.     CrossRef
  • Physical activity level, sitting time, and skeletal muscle mass between esports players and non-esports players
    Zhi H. SEE, Mohamad S. ABDUL HAMID
    Gazzetta Medica Italiana Archivio per le Scienze Mediche.2022;[Epub]     CrossRef
  • Associations of changes in fat free mass with risk for type 2 diabetes: Hispanic Community Health Study/Study of Latinos
    M.N. LeCroy, S. Hua, R.C. Kaplan, D. Sotres-Alvarez, Q. Qi, B. Thyagarajan, L.C. Gallo, A. Pirzada, M.L. Daviglus, N. Schneiderman, G.A. Talavera, C.R. Isasi
    Diabetes Research and Clinical Practice.2021; 171: 108557.     CrossRef
  • The phospholipase A2 family’s role in metabolic diseases: Focus on skeletal muscle
    Iris Prunonosa Cervera, Brendan M. Gabriel, Peter Aldiss, Nicholas M. Morton
    Physiological Reports.2021;[Epub]     CrossRef
  • Bone Health in Aging Men: Does Zinc and Cuprum Level Matter?
    Aleksandra Rył, Tomasz Miazgowski, Aleksandra Szylińska, Agnieszka Turoń-Skrzypińska, Alina Jurewicz, Andrzej Bohatyrewicz, Iwona Rotter
    Biomolecules.2021; 11(2): 237.     CrossRef
  • Animal Protein versus Plant Protein in Supporting Lean Mass and Muscle Strength: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Meng Thiam Lim, Bernice Jiaqi Pan, Darel Wee Kiat Toh, Clarinda Nataria Sutanto, Jung Eun Kim
    Nutrients.2021; 13(2): 661.     CrossRef
  • Effects of Exercise Intervention on Mitochondrial Stress Biomarkers in Metabolic Syndrome Patients: A Randomized Controlled Trial
    Jae Seung Chang, Jun Namkung
    International Journal of Environmental Research and Public Health.2021; 18(5): 2242.     CrossRef
  • Association between sarcopenia level and metabolic syndrome
    Su Hwan Kim, Ji Bong Jeong, Jinwoo Kang, Dong-Won Ahn, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee, Sohee Oh, Soon Ho Yoon, Sang Joon Park, Doo Hee Lee, Masaki Mogi
    PLOS ONE.2021; 16(3): e0248856.     CrossRef
  • Sarcopenia and Appendicular Muscle Mass as Predictors of Impaired Fasting Glucose/Type 2 Diabetes in Elderly Women
    Carola Buscemi, Yvelise Ferro, Roberta Pujia, Elisa Mazza, Giada Boragina, Angela Sciacqua, Salvatore Piro, Arturo Pujia, Giorgio Sesti, Silvio Buscemi, Tiziana Montalcini
    Nutrients.2021; 13(6): 1909.     CrossRef
  • Low muscle mass in older adults and mortality: A systematic review and meta-analysis
    Felipe M. de Santana, Melissa O. Premaor, Nicolas Y. Tanigava, Rosa M.R. Pereira
    Experimental Gerontology.2021; 152: 111461.     CrossRef
  • Association of obesity, visceral adiposity, and sarcopenia with an increased risk of metabolic syndrome: A retrospective study
    Su Hwan Kim, Hyoun Woo Kang, Ji Bong Jeong, Dong Seok Lee, Dong-Won Ahn, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee, Sohee Oh, Soon Ho Yoon, Sang Joon Park, Mauro Lombardo
    PLOS ONE.2021; 16(8): e0256083.     CrossRef
  • Der Muskulatur mehr Aufmerksamkeit schenken!
    Wolfgang Laube
    Manuelle Medizin.2021; 59(4): 302.     CrossRef
  • Dietary Protein Requirement Threshold and Micronutrients Profile in Healthy Older Women Based on Relative Skeletal Muscle Mass
    Praval Khanal, Lingxiao He, Hans Degens, Georgina K. Stebbings, Gladys L. Onambele-Pearson, Alun G. Williams, Martine Thomis, Christopher I. Morse
    Nutrients.2021; 13(9): 3076.     CrossRef
  • Effects of different definitions of low muscle mass on its association with metabolic syndrome in older adults: A Korean nationwide study
    Yerim Jeon, Ki Young Son
    Geriatrics & Gerontology International.2021; 21(11): 1003.     CrossRef
  • Musclin Is Related to Insulin Resistance and Body Composition, but Not to Body Mass Index or Cardiorespiratory Capacity in Adults
    Yeliana L. Sánchez, Manuela Yepes-Calderón, Luis Valbuena, Andrés F. Milán, María C. Trillos-Almanza, Sergio Granados, Miguel Peña, Mauricio Estrada-Castrillón, Juan C. Aristizábal, Raúl Narvez-Sanchez, Jaime Gallo-Villegas, Juan C. Calderón
    Endocrinology and Metabolism.2021; 36(5): 1055.     CrossRef
  • Relative Lean Body Mass and Waist Circumference for the Identification of Metabolic Syndrome in the Korean General Population
    Eunjoo Kwon, Eun-Hee Nah, Suyoung Kim, Seon Cho
    International Journal of Environmental Research and Public Health.2021; 18(24): 13186.     CrossRef
  • Impact of Skeletal Muscle Mass on Metabolic Health
    Gyuri Kim, Jae Hyeon Kim
    Endocrinology and Metabolism.2020; 35(1): 1.     CrossRef
  • Skeletal muscle area and density are associated with lipid and lipoprotein cholesterol levels: The Multi-Ethnic Study of Atherosclerosis
    Chantal A. Vella, Megan C. Nelson, Jonathan T. Unkart, Iva Miljkovic, Matthew A. Allison
    Journal of Clinical Lipidology.2020; 14(1): 143.     CrossRef
  • Creatinine/(cystatin C × body weight) ratio is associated with skeletal muscle mass index
    Kensuke Nishida, Yoshitaka Hashimoto, Ayumi Kaji, Takuro Okamura, Ryousuke Sakai, Noriyuki Kitagawa, Takafumi Osaka, Masahide Hamaguchi, Michiaki Fukui
    Endocrine Journal.2020; 67(7): 733.     CrossRef
  • Testosterone Therapy for Prevention and Treatment of Obesity in Men
    Monica Caliber, Farid Saad
    Androgens: Clinical Research and Therapeutics.2020; 1(1): 40.     CrossRef
  • Creatinine to Body Weight Ratio Is Associated with Incident Diabetes: Population-Based Cohort Study
    Yoshitaka Hashimoto, Takuro Okamura, Masahide Hamaguchi, Akihiro Obora, Takao Kojima, Michiaki Fukui
    Journal of Clinical Medicine.2020; 9(1): 227.     CrossRef
  • Skeletal muscle – A bystander or influencer of metabolic syndrome?
    Gina L. Richter-Stretton, Andrew S. Fenning, Rebecca K. Vella
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2020; 14(5): 867.     CrossRef
  • Using relative handgrip strength to identify children at risk of sarcopenic obesity
    Seryozha Gontarev, Mirko Jakimovski, Georgi Georgiev
    Nutrición Hospitalaria.2020;[Epub]     CrossRef
  • Nonalcoholic Fatty Liver Disease Is Associated With Low Skeletal Muscle Mass in Overweight/Obese Youths
    Lucia Pacifico, Francesco Massimo Perla, Gianmarco Andreoli, Rosangela Grieco, Pasquale Pierimarchi, Claudio Chiesa
    Frontiers in Pediatrics.2020;[Epub]     CrossRef
  • Independent and combined associations of cardiorespiratory fitness and muscle strength with metabolic syndrome in older adults: A cross-sectional study
    Marcyo Câmara, Rodrigo Alberto Vieira Browne, Gabriel Costa Souto, Daniel Schwade, Ludmila Pereira Lucena Cabral, Geovani Araújo Dantas Macêdo, Luiz Fernando Farias-Junior, Fabíola Leite Gouveia, Telma Maria Araújo Moura Lemos, Kenio Costa Lima, Todd A. D
    Experimental Gerontology.2020; 135: 110923.     CrossRef
  • A counterintuitive perspective for the role of fat‐free mass in metabolic health
    Jean‐Christophe Lagacé, Martin Brochu, Isabelle J. Dionne
    Journal of Cachexia, Sarcopenia and Muscle.2020; 11(2): 343.     CrossRef
  • Response: The way fat‐free mass is reported may change the conclusions regarding its protective effect on metabolic health
    Jean‐Christophe Lagace, Martin Brochu, Isabelle J. Dionne
    Clinical Endocrinology.2020; 92(1): 79.     CrossRef
  • The Association between Major Dietary Pattern and Low Muscle Mass in Korean Middle-Aged and Elderly Populations: Based on the Korea National Health and Nutrition Examination Survey
    Seong-Ah Kim, Jinwoo Ha, Byeonghwi Lim, Jun-Mo Kim, Sangah Shin
    Nutrients.2020; 12(11): 3543.     CrossRef
  • Total body skeletal muscle mass and diet in children aged 6–8 years: ANIVA Study
    Maria Morales-Suarez-Varela, Isabel Peraita-Costa, Carlos Guillamon Escudero, Agustin Llopis-Morales, Agustin Llopis-Gonzalez
    Applied Physiology, Nutrition, and Metabolism.2019; 44(9): 944.     CrossRef
  • The way fat‐free mass is reported may change the conclusions regarding its protective effect on metabolic health
    Jean‐Christophe Lagacé, Dominic Tremblay, Jasmine Paquin, Alexis Marcotte‐Chénard, Martin Brochu, Isabelle J. Dionne
    Clinical Endocrinology.2019; 91(6): 903.     CrossRef
  • Components of Metabolic Syndrome in Korean Adults: A Hospital-Based Cohort at Seoul National University Bundang Hospital
    Soo Lim, Se Hee Min, Ji Hyun Lee, Lee Kyung Kim, Dong-Hwa Lee, Jie-Eun Lee, Kyoung Min Kim, Sunmi Lee, Kyoung-Chan Park, Yun Jong Lee
    Journal of Obesity & Metabolic Syndrome.2019; 28(2): 118.     CrossRef
  • Skeletal muscle as a protagonist in the pregnancy metabolic syndrome
    Raul Narvaez-Sanchez, Juan C. Calderón, Gloria Vega, Maria Camila Trillos, Sara Ospina
    Medical Hypotheses.2019; 126: 26.     CrossRef
  • Increase in relative skeletal muscle mass over time and its inverse association with metabolic syndrome development: a 7-year retrospective cohort study
    Gyuri Kim, Seung-Eun Lee, Ji Eun Jun, You-Bin Lee, Jiyeon Ahn, Ji Cheol Bae, Sang-Man Jin, Kyu Yeon Hur, Jae Hwan Jee, Moon-Kyu Lee, Jae Hyeon Kim
    Cardiovascular Diabetology.2018;[Epub]     CrossRef
  • Association of Age-Related Trends in Blood Pressure and Body Composition Indices in Healthy Adults
    Wei Li, Yan He, Lili Xia, Xinghua Yang, Feng Liu, Jingang Ma, Zhiping Hu, Yajun Li, Dongxue Li, Jiajia Jiang, Guangliang Shan, Changlong Li
    Frontiers in Physiology.2018;[Epub]     CrossRef
  • Metabolic syndrome and body shape predict differences in health parameters in farm working women
    Ilze Mentoor, Maritza Kruger, Theo Nell
    BMC Public Health.2018;[Epub]     CrossRef
  • Associations of stunting in early childhood with cardiometabolic risk factors in adulthood
    Emanuella De Lucia Rolfe, Giovanny Vinícius Araújo de França, Carolina Avila Vianna, Denise P. Gigante, J. Jaime Miranda, John S. Yudkin, Bernardo Lessa Horta, Ken K. Ong, C. Mary Schooling
    PLOS ONE.2018; 13(4): e0192196.     CrossRef
  • Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7‐Year Longitudinal Study
    Gyuri Kim, Seung‐Eun Lee, You‐Bin Lee, Ji Eun Jun, Jiyeon Ahn, Ji Cheol Bae, Sang‐Man Jin, Kyu Yeon Hur, Jae Hwan Jee, Moon‐Kyu Lee, Jae Hyeon Kim
    Hepatology.2018; 68(5): 1755.     CrossRef
  • Relationships among Skeletal Muscle Mass, Health Related Factors, Nutrient Intake, and Physical Activities in Male Adolescents: Based on the 5th (2009-2011) Korean National Health and Nutrition Examination Survey (KNHANES)
    In-Kyung Jung, Jung-Hyun Kim
    The Korean Journal of Community Living Science.2018; 29(2): 185.     CrossRef
  • Using relative handgrip strength to identify children at risk of sarcopenic obesity
    Michal Steffl, Jan Chrudimsky, James J. Tufano, Masaki Mogi
    PLOS ONE.2017; 12(5): e0177006.     CrossRef
  • International society of sports nutrition position stand: diets and body composition
    Alan A. Aragon, Brad J. Schoenfeld, Robert Wildman, Susan Kleiner, Trisha VanDusseldorp, Lem Taylor, Conrad P. Earnest, Paul J. Arciero, Colin Wilborn, Douglas S. Kalman, Jeffrey R. Stout, Darryn S. Willoughby, Bill Campbell, Shawn M. Arent, Laurent Banno
    Journal of the International Society of Sports Nutrition.2017;[Epub]     CrossRef
  • Relationship between rectus abdominis muscle thickness and metabolic syndrome in middle-aged men
    Eun Sil Choi, Soo Hyun Cho, Jung-Ha Kim, Etsuro Ito
    PLOS ONE.2017; 12(9): e0185040.     CrossRef
  • Health-related quality of life and activity limitation in an elderly Korean population with sarcopenia: The Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV-2, 3), 2008–2009
    T.H. Kim, S.-H. Kim, J. Kim, H.-J. Hwang
    European Geriatric Medicine.2017; 8(4): 360.     CrossRef
  • Differential association between sarcopenia and metabolic phenotype in Korean young and older adults with and without obesity
    You‐Cheol Hwang, In‐Jin Cho, In‐Kyung Jeong, Kyu Jeung Ahn, Ho Yeon Chung
    Obesity.2017; 25(1): 244.     CrossRef
  • Reference Values of Skeletal Muscle Mass for Korean Children and Adolescents Using Data from the Korean National Health and Nutrition Examination Survey 2009-2011
    Kirang Kim, Sangmo Hong, Eun Young Kim, Bin He
    PLOS ONE.2016; 11(4): e0153383.     CrossRef
  • Insulin sensitivity, body composition and adipose depots following 12 w combined endurance and strength training in dysglycemic and normoglycemic sedentary men
    Torgrim Mikal Langleite, Jørgen Jensen, Frode Norheim, Hanne Løvdal Gulseth, Daniel Steensen Tangen, Kristoffer Jensen Kolnes, Ansgar Heck, Tryggve Storås, Guro Grøthe, Marius Adler Dahl, Anders Kielland, Torgeir Holen, Hans Jørgen Noreng, Hans Kristian S
    Archives of Physiology and Biochemistry.2016; 122(4): 167.     CrossRef
  • Association between fat free mass and glucose homeostasis: Common knowledge revisited
    Karine Perreault, Jean-Christophe Lagacé, Martin Brochu, Isabelle J. Dionne
    Ageing Research Reviews.2016; 28: 46.     CrossRef
  • Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey
    Hee Yeon Kim, Chang Wook Kim, Chung-Hwa Park, Jong Young Choi, Kyungdo Han, Anwar T Merchant, Yong-Moon Park
    Hepatobiliary & Pancreatic Diseases International.2016; 15(1): 39.     CrossRef
  • The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype
    You-Cheol Hwang, Won Seon Jeon, Cheol-Young Park, Byung-Soo Youn
    Cardiovascular Diabetology.2016;[Epub]     CrossRef
  • Effects of a weight loss program on body composition and the metabolic profile in obese postmenopausal women displaying various obesity phenotypes: a MONET group study
    Eve Normandin, Eric Doucet, Rémi Rabasa-Lhoret, Martin Brochu
    Applied Physiology, Nutrition, and Metabolism.2015; 40(7): 695.     CrossRef
  • Analytic morphomics identifies predictors of new‐onset diabetes after liver transplantation
    Valerie M. Vaughn, David C. Cron, Michael N. Terjimanian, Zachary S. Gala, Stewart C. Wang, Grace L. Su, Michael L. Volk
    Clinical Transplantation.2015; 29(5): 458.     CrossRef
  • Reduced Flexibility Associated with Metabolic Syndrome in Community-Dwelling Elders
    Ke-Vin Chang, Chen-Yu Hung, Chia-Ming Li, Yu-Hung Lin, Tyng-Guey Wang, Keh-Sung Tsai, Der-Sheng Han, Diego Fraidenraich
    PLOS ONE.2015; 10(1): e0117167.     CrossRef
  • Metabolic risk factors in U.S. youth with low relative muscle mass
    Sunkyung Kim, Rodolfo Valdez
    Obesity Research & Clinical Practice.2015; 9(2): 125.     CrossRef
  • Comparison of waist to height ratio and body indices for prediction of metabolic disturbances in the Korean population: the Korean National Health and Nutrition Examination Survey 2008–2011
    Seok Hui Kang, Kyu Hyang Cho, Jong Won Park, Jun Young Do
    BMC Endocrine Disorders.2015;[Epub]     CrossRef
  • N-3 fatty acid intake altered fat content and fatty acid distribution in chicken breast muscle, but did not influence mRNA expression of lipid-related enzymes
    Anna Haug, Nicole F Nyquist, Magny Thomassen, Arne T Høstmark, Tone-Kari Knutsdatter Østbye
    Lipids in Health and Disease.2014;[Epub]     CrossRef
  • Métodos de análise da composição corporal em adultos obesos
    Rávila Graziany Machado de Souza, Aline Corado Gomes, Carla Marques Maia do Prado, João Felipe Mota
    Revista de Nutrição.2014; 27(5): 569.     CrossRef
Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients
Young Ki Lee, Sun Ok Song, Kwang Joon Kim, Yongin Cho, Younjeong Choi, Yujung Yun, Byung-Wan Lee, Eun-Seok Kang, Bong Soo Cha, Hyun Chul Lee
Diabetes Metab J. 2013;37(6):465-474.   Published online December 12, 2013
DOI: https://doi.org/10.4093/dmj.2013.37.6.465
  • 5,103 View
  • 67 Download
  • 17 Crossref
AbstractAbstract PDFPubReader   
Background

This study compared the glycemic effectiveness of three metformin-based dual therapies according to baseline hemoglobin A1c (HbA1c) to evaluate the appropriateness of the guideline enforced by the National Health Insurance Corporation of Korea for initial medication of type 2 diabetes (T2D).

Methods

This prospective observational study was conducted across 24 weeks for drug-naïve Korean T2D patients with HbA1c greater than 7.5%. Subjects were first divided into three groups based on the agent combined with metformin (group 1, gliclazide-modified release or glimepiride; group 2, pioglitazone; group 3, sitagliptin). Subjects were also classified into three categories according to baseline HbA1c (category I, 7.5%≤HbA1c<9.0%; category II, 9.0%≤HbA1c<11.0%; category III, 11.0%≤HbA1c).

Results

Among 116 subjects, 99 subjects completed the study, with 88 subjects maintaining the initial medication. While each of the metformin-based dual therapies showed a significant decrease in HbA1c (group 1, 8.9% to 6.4%; group 2, 9.0% to 6.6%; group 3, 9.3% to 6.3%; P<0.001 for each), there was no significant difference in the magnitude of HbA1c change among the groups. While the three HbA1c categories showed significantly different baseline HbA1c levels (8.2% vs. 9.9% vs. 11.9%; P<0.001), endpoint HbA1c was not different (6.4% vs. 6.6% vs. 6.0%; P=0.051).

Conclusion

The three dual therapies using a combination of metformin and either sulfonylurea, pioglitazone, or sitagliptin showed similar glycemic effectiveness among drug-naïve Korean T2D patients. In addition, these regimens were similarly effective across a wide range of baseline HbA1c levels.

Citations

Citations to this article as recorded by  
  • Benefits and risks of drug combination therapy for diabetes mellitus and its complications: a comprehensive review
    Xueqin Xie, Changchun Wu, Yuduo Hao, Tianyu Wang, Yuhe Yang, Peiling Cai, Yang Zhang, Jian Huang, Kejun Deng, Dan Yan, Hao Lin
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Estimation of Serum Creatinine, Aspartate Aminotransferase, Alanine Transaminase, and Hemoglobin A1c% Levels among Diabetic Patients using Metformin/Dipeptide Peptidase-4 Inhibitor Combination and Insulin – A Cross-Sectional Study
    Arshiya Shadab, Ilma Hussain, Praveen Kumar Kandakurti, Marwan Ismail, Ahmed Luay Osman Hashim, Salah Eldin Omar Hussein, Altoum Abd Elgadir
    Open Access Macedonian Journal of Medical Sciences.2022; 10(B): 959.     CrossRef
  • Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
    Hae Kyung Yang, Seung-Hwan Lee, Juyoung Shin, Yoon-Hee Choi, Yu-Bae Ahn, Byung-Wan Lee, Eun Jung Rhee, Kyung Wan Min, Kun-Ho Yoon
    Diabetes & Metabolism Journal.2019; 43(3): 287.     CrossRef
  • Initial combination therapy with vildagliptin plus metformin in drug-naïve patients with T2DM: a 24-week real-life study from Asia
    Manoj Chawla, Tae Ho Kim, Roberto C. Mirasol, Pathan Faruque, Kathryn Cooke, Peggy Hours-Zesiger, Abhijit Shete
    Current Medical Research and Opinion.2018; 34(9): 1605.     CrossRef
  • Consensus recommendations on sulfonylurea and sulfonylurea combinations in the management of Type 2 diabetes mellitus – International Task Force
    Sanjay Kalra, Silver Bahendeka, Rakesh Sahay, Sujoy Ghosh, Fariduddin Md, Abbas Orabi, Kaushik Ramaiya, Sameer Al Shammari, Dina Shrestha, Khalid Shaikh, Sachitha Abhayaratna, PradeepK Shrestha, Aravinthan Mahalingam, Mazen Askheta, AlyAhmed A. Rahim, Fat
    Indian Journal of Endocrinology and Metabolism.2018; 22(1): 132.     CrossRef
  • Efficacy and safety of sitagliptin/metformin fixed‐dose combination compared with glimepiride in patients with type 2 diabetes: A multicenter randomized double‐blind study
    Sang Soo Kim, In Joo Kim, Kwang Jae Lee, Jeong Hyun Park, Young Il Kim, Young Sil Lee, Sung Chang Chung, Sang Jin Lee
    Journal of Diabetes.2017; 9(4): 412.     CrossRef
  • Short‐term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9%
    Jianping Weng
    Journal of Diabetes.2017; 9(10): 890.     CrossRef
  • The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus
    Gyuri Kim, Sewon Oh, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim, Moon-Kyu Lee
    Expert Opinion on Pharmacotherapy.2017; 18(12): 1179.     CrossRef
  • Effects of pioglitazone therapy on blood parameters, weight and BMI: a meta-analysis
    Elena Filipova, Katya Uzunova, Krassimir Kalinov, Toni Vekov
    Diabetology & Metabolic Syndrome.2017;[Epub]     CrossRef
  • Is insulin the preferred treatment for HbA1c >9%?
    Zachary Bloomgarden
    Journal of Diabetes.2017; 9(9): 814.     CrossRef
  • The effect of pioglitazone on weight, lipid profile and liver enzymes in type 2 diabetic patients
    Nasser Aghamohammadzadeh, Mitra Niafar, Elham Dalir Abdolahinia, Farzad Najafipour, Saeed Mohamadzadeh Gharebaghi, Khadijeh Adabi, Elaheh Dalir Abdolahinia, Hamidreza Ahadi
    Therapeutic Advances in Endocrinology and Metabolism.2015; 6(2): 56.     CrossRef
  • Glycated Albumin Levels in Patients with Type 2 Diabetes Increase Relative to HbA1cwith Time
    Hye-jin Yoon, Yong-ho Lee, Kwang Joon Kim, So Ra Kim, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Byung-Wan Lee
    BioMed Research International.2015; 2015: 1.     CrossRef
  • Four-Year Durability of Initial Combination Therapy with Sitagliptin and Metformin in Patients with Type 2 Diabetes in Clinical Practice; COSMIC Study
    Eu Jeong Ku, Kyong Yeon Jung, Yoon Ji Kim, Kyoung Min Kim, Jae Hoon Moon, Sung Hee Choi, Young Min Cho, Kyong Soo Park, Hak Chul Jang, Soo Lim, Bo Ahrén, Giorgio Sesti
    PLOS ONE.2015; 10(6): e0129477.     CrossRef
  • Comparative analysis of therapeutic efficiency and costs (experience in Bulgaria) of oral antidiabetic therapies based on glitazones and gliptins
    Elena Pavlova Filipova, Katya Hristova Uzunova, Toni Yonkov Vekov
    Diabetology & Metabolic Syndrome.2015;[Epub]     CrossRef
  • Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition
    Sen Shi, Swayam Prakash Srivastava, Megumi Kanasaki, Jianhua He, Munehiro Kitada, Takako Nagai, Kyoko Nitta, Susumu Takagi, Keizo Kanasaki, Daisuke Koya
    Kidney International.2015; 88(3): 479.     CrossRef
  • Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors: New among Antidiabetic Drugs
    L. H. Opie
    Cardiovascular Drugs and Therapy.2014; 28(4): 331.     CrossRef
  • Metformin Based Dual-Combination Therapies in Drug Naïve Type 2 Diabetic Patients
    Dong-Lim Kim
    Diabetes & Metabolism Journal.2013; 37(6): 429.     CrossRef
Pattern of Stress-Induced Hyperglycemia according to Type of Diabetes: A Predator Stress Model
Jin-Sun Chang, Young-Hye You, Shin-Young Park, Ji-Won Kim, Hun-Sung Kim, Kun-Ho Yoon, Jae-Hyoung Cho
Diabetes Metab J. 2013;37(6):475-483.   Published online December 12, 2013
DOI: https://doi.org/10.4093/dmj.2013.37.6.475
  • 4,051 View
  • 50 Download
  • 5 Crossref
AbstractAbstract PDFPubReader   
Background

We aimed to quantify stress-induced hyperglycemia and differentiate the glucose response between normal animals and those with diabetes. We also examined the pattern in glucose fluctuation induced by stress according to type of diabetes.

Methods

To load psychological stress on animal models, we used a predator stress model by exposing rats to a cat for 60 minutes and measured glucose level from the beginning to the end of the test to monitor glucose fluctuation. We induced type 1 diabetes model (T1D) for ten Sprague-Dawley rats using streptozotocin and used five Otsuka Long-Evans Tokushima Fatty rats as obese type 2 diabetes model (OT2D) and 10 Goto-Kakizaki rats as nonobese type 2 diabetes model (NOT2D). We performed the stress loading test in both the normal and diabetic states and compared patterns of glucose fluctuation among the three models. We classified the pattern of glucose fluctuation into A, B, and C types according to speed of change in glucose level.

Results

Increase in glucose, total amount of hyperglycemic exposure, time of stress-induced hyperglycemia, and speed of glucose increase were significantly increased in all models compared to the normal state. While the early increase in glucose after exposure to stress was higher in T1D and NOT2D, it was slower in OT2D. The rate of speed of the decrease in glucose level was highest in NOT2D and lowest in OT2D.

Conclusion

The diabetic state was more vulnerable to stress compared to the normal state in all models, and the pattern of glucose fluctuation differed among the three types of diabetes. The study provides basic evidence for stress-induced hyperglycemia patterns and characteristics used for the management of diabetes patients.

Citations

Citations to this article as recorded by  
  • Stress hyperglycemia as first sign of asymptomatic type 1 diabetes: an instructive case
    Wei-De Wang, Chun-Hao Chu, Chiung-Hsi Tien, Shuo-Yu Wang, Shih-Yao Liu, Chien-Ming Lin
    BMC Pediatrics.2021;[Epub]     CrossRef
  • Genetic determinants of obesity heterogeneity in type II diabetes
    Somayeh Alsadat Hosseini Khorami, Mohd Sokhini Abd Mutalib, Mohammad Feili Shiraz, Joseph Anthony Abdullah, Zulida Rejali, Razana Mohd Ali, Huzwah Khaza’ai
    Nutrition & Metabolism.2020;[Epub]     CrossRef
  • Sex Dimorphic Responses of the Hypothalamus–Pituitary–Thyroid Axis to Maternal Separation and Palatable Diet
    Lorraine Jaimes-Hoy, Fidelia Romero, Jean-Louis Charli, Patricia Joseph-Bravo
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
  • Hesperidin protects against stress induced gastric ulcer through regulation of peroxisome proliferator activator receptor gamma in diabetic rats
    Shimaa M. Elshazly, Dalia M. Abd El Motteleb, Islam A.A.E-H. Ibrahim
    Chemico-Biological Interactions.2018; 291: 153.     CrossRef
  • Physiology and Neurobiology of Stress and the Implications for Physical Health
    B Sivaprakash
    Annals of SBV.2014; 3(1): 25.     CrossRef
Letter
Letter: Predicting Mortality of Critically Ill Patients by Blood Glucose Levels (Diabetes Metab J 2013;37:385-90)
Hyeong Kyu Park
Diabetes Metab J. 2013;37(6):484-485.   Published online December 12, 2013
DOI: https://doi.org/10.4093/dmj.2013.37.6.484
  • 2,366 View
  • 30 Download
PDFPubReader   
Erratums
Erratum: Figure Correction. Intestinal and Hepatic Niemann-Pick C1-Like 1
Sung-Woo Park
Diabetes Metab J. 2013;37(6):486-487.   Published online December 12, 2013
DOI: https://doi.org/10.4093/dmj.2013.37.6.486
  • 2,456 View
  • 31 Download
PDFPubReader   
Erratum: Author's Name Correction. Diabetic Retinopathy and Endothelial Dysfunction in Patients with Type 2 Diabetes Mellitus
Jae-Seung Yun, Seung-Hyun Ko, Ji-Hoon Kim, Keon-Woong Moon, Yong-Moon Park, Ki-Dong Yoo, Yu-Bae Ahn
Diabetes Metab J. 2013;37(6):488-488.   Published online December 12, 2013
DOI: https://doi.org/10.4093/dmj.2013.37.6.488
  • 2,695 View
  • 23 Download
  • 1 Crossref
PDFPubReader   

Citations

Citations to this article as recorded by  
  • Endothelial dysfunction and cardiovascular diseases: The role of human induced pluripotent stem cells and tissue engineering
    Mary H. C. Florido, Nicholas P. Ziats
    Journal of Biomedical Materials Research Part A.2024;[Epub]     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal